-
1
-
-
0024509701
-
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
-
[CrossRef] [PubMed]
-
Choo, Q.L.; Kuo, G.; Weiner, A.J.; Overby, L.R.; Bradley, D.W.; Houghton, M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244, 359–362. [CrossRef] [PubMed]
-
(1989)
Science
, vol.244
, pp. 359-362
-
-
Choo, Q.L.1
Kuo, G.2
Weiner, A.J.3
Overby, L.R.4
Bradley, D.W.5
Houghton, M.6
-
2
-
-
84897104214
-
Natural reservoirs for homologs of hepatitis C virus
-
[CrossRef] [PubMed]
-
Pfaender, S.; Brown, R.J.P.; Pietschmann, T. Natural reservoirs for homologs of hepatitis C virus. Emerg. Microbes Infect. 2014, 3, e21. [CrossRef] [PubMed]
-
(2014)
Emerg. Microbes Infect
, vol.3
-
-
Pfaender, S.1
Brown, R.2
Pietschmann, T.3
-
3
-
-
84894128830
-
Murine models of hepatitis C: What can we look forward to?
-
[CrossRef] [PubMed]
-
Von Schaewen, M.; Ploss, A. Murine models of hepatitis C: What can we look forward to? Antivir. Res. 2014, 104, 15–22. [CrossRef] [PubMed]
-
(2014)
Antivir. Res
, vol.104
, pp. 15-22
-
-
Von Schaewen, M.1
Ploss, A.2
-
4
-
-
23944506014
-
Global epidemiology of hepatitis C virus infection
-
[CrossRef]
-
Shepard, C.W.; Finelli, L.; Alter, M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005, 5, 558–567. [CrossRef]
-
(2005)
Lancet Infect. Dis
, vol.5
, pp. 558-567
-
-
Shepard, C.W.1
Finelli, L.2
Alter, M.J.3
-
5
-
-
84914150658
-
Global epidemiology and genotype distribution of the hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Gower, E.; Estes, C.; Blach, S.; Razavi-Shearer, K.; Razavi, H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 2014, 61(Suppl. S1), S45–S57. [CrossRef] [PubMed]
-
(2014)
J. Hepatol
, vol.61
-
-
Gower, E.1
Estes, C.2
Blach, S.3
Razavi-Shearer, K.4
Razavi, H.5
-
6
-
-
77956832815
-
Characterization of the envelope glycoproteins associated with infectious hepatitis C virus
-
[CrossRef] [PubMed]
-
Vieyres, G.; Thomas, X.; Descamps, V.; Duverlie, G.; Patel, A.H.; Dubuisson, J. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J. Virol. 2010, 84, 10159–10168. [CrossRef] [PubMed]
-
(2010)
J. Virol
, vol.84
, pp. 10159-10168
-
-
Vieyres, G.1
Thomas, X.2
Descamps, V.3
Duverlie, G.4
Patel, A.H.5
Dubuisson, J.6
-
7
-
-
33745771735
-
Hepatitis C virus entry depends on clathrin-mediated endocytosis
-
[CrossRef] [PubMed]
-
Blanchard, E.; Belouzard, S.; Goueslain, L.; Wakita, T.; Dubuisson, J.; Wychowski, C.; Rouille, Y. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 2006, 80, 6964–6972. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 6964-6972
-
-
Blanchard, E.1
Belouzard, S.2
Goueslain, L.3
Wakita, T.4
Dubuisson, J.5
Wychowski, C.6
Rouille, Y.7
-
8
-
-
33751223214
-
Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles
-
[CrossRef] [PubMed]
-
Meertens, L.; Bertaux, C.; Dragic, T. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J. Virol. 2006, 80, 11571–11578. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 11571-11578
-
-
Meertens, L.1
Bertaux, C.2
Dragic, T.3
-
9
-
-
32444435210
-
Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry
-
[CrossRef] [PubMed]
-
Tscherne, D.M.; Jones, C.T.; Evans, M.J.; Lindenbach, B.D.; McKeating, J.A.; Rice, C.M. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J. Virol. 2006, 80, 1734–1741. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 1734-1741
-
-
Tscherne, D.M.1
Jones, C.T.2
Evans, M.J.3
Lindenbach, B.D.4
McKeating, J.A.5
Rice, C.M.6
-
10
-
-
0037416146
-
Virus pseudo-particles containing functional E1-E2 envelope protein complexes
-
[CrossRef] [PubMed]
-
Bartosch, B.; Dubuisson, J.; Cosset, F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 2003, 197, 633–642. [CrossRef] [PubMed]
-
(2003)
J. Exp. Med
, vol.197
, pp. 633-642
-
-
Bartosch, B.1
Dubuisson, J.2
Cosset, F.L.3
Infectious Hepatitis, C.4
-
11
-
-
19944432537
-
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus
-
[CrossRef] [PubMed]
-
Lavillette, D.; Tarr, A.W.; Voisset, C.; Donot, P.; Bartosch, B.; Bain, C.; Patel, A.H.; Dubuisson, J.; Ball, J.K.; Cosset, F.L. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 2005, 41, 265–274. [CrossRef] [PubMed]
-
(2005)
Hepatology
, vol.41
, pp. 265-274
-
-
Lavillette, D.1
Tarr, A.W.2
Voisset, C.3
Donot, P.4
Bartosch, B.5
Bain, C.6
Patel, A.H.7
Dubuisson, J.8
Ball, J.K.9
Cosset, F.L.10
-
12
-
-
0038471344
-
Virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
-
[CrossRef] [PubMed]
-
Hsu, M.; Zhang, J.; Flint, M.; Logvinoff, C.; Cheng-Mayer, C.; Rice, C.M.; McKeating, J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. USA 2003, 100, 7271–7276. [CrossRef] [PubMed]
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 7271-7276
-
-
Hsu, M.1
Zhang, J.2
Flint, M.3
Logvinoff, C.4
Cheng-Mayer, C.5
Rice, C.M.6
McKeating, J.A.7
Hepatitis, C.8
-
13
-
-
0032582538
-
Binding of hepatitis C virus to CD81
-
[CrossRef] [PubMed]
-
Pileri, P.; Uematsu, Y.; Campagnoli, S.; Galli, G.; Falugi, F.; Petracca, R.; Weiner, A.J.; Houghton, M.; Rosa, D.; Grandi, G., et al. Binding of hepatitis C virus to CD81. Science 1998, 282, 938–941. [CrossRef] [PubMed]
-
(1998)
Science
, vol.282
, pp. 938-941
-
-
Pileri, P.1
Uematsu, Y.2
Campagnoli, S.3
Galli, G.4
Falugi, F.5
Petracca, R.6
Weiner, A.J.7
Houghton, M.8
Rosa, D.9
Grandi, G.10
-
14
-
-
18644378971
-
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
-
[CrossRef] [PubMed]
-
Scarselli, E.; Ansuini, H.; Cerino, R.; Roccasecca, R.M.; Acali, S.; Filocamo, G.; Traboni, C.; Nicosia, A.; Cortese, R.; Vitelli, A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002, 21, 5017–5025. [CrossRef] [PubMed]
-
(2002)
EMBO J
, vol.21
, pp. 5017-5025
-
-
Scarselli, E.1
Ansuini, H.2
Cerino, R.3
Roccasecca, R.M.4
Acali, S.5
Filocamo, G.6
Traboni, C.7
Nicosia, A.8
Cortese, R.9
Vitelli, A.10
-
15
-
-
0034959095
-
Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2
-
[PubMed]
-
Cocquerel, L.; Meunier, J.C.; Op de Beeck, A.; Bonte, D.; Wychowski, C.; Dubuisson, J. Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2. J. Gen. Virol. 2001, 82, 1629–1635. [PubMed]
-
(2001)
J. Gen. Virol
, vol.82
, pp. 1629-1635
-
-
Cocquerel, L.1
Meunier, J.C.2
De Op Beeck, A.3
Bonte, D.4
Wychowski, C.5
Dubuisson, J.6
-
16
-
-
0034031173
-
Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins
-
[CrossRef] [PubMed]
-
Cocquerel, L.; Wychowski, C.; Minner, F.; Penin, F.; Dubuisson, J. Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. J. Virol. 2000, 74, 3623–3633. [CrossRef] [PubMed]
-
(2000)
J. Virol
, vol.74
, pp. 3623-3633
-
-
Cocquerel, L.1
Wychowski, C.2
Minner, F.3
Penin, F.4
Dubuisson, J.5
-
17
-
-
78951475433
-
Identification of new functional regions in hepatitis C virus envelope glycoprotein E2
-
[CrossRef] [PubMed]
-
Albecka, A.; Montserret, R.; Krey, T.; Tarr, A.W.; Diesis, E.; Ball, J.K.; Descamps, V.; Duverlie, G.; Rey, F.; Penin, F., et al. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2. J. Virol. 2011, 85, 1777–1792. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 1777-1792
-
-
Albecka, A.1
Montserret, R.2
Krey, T.3
Tarr, A.W.4
Diesis, E.5
Ball, J.K.6
Descamps, V.7
Duverlie, G.8
Rey, F.9
Penin, F.10
-
18
-
-
79551713699
-
Production of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans
-
[CrossRef] [PubMed]
-
Li, R.; Qin, Y.; He, Y.; Tao, W.; Zhang, N.; Tsai, C.; Zhou, P.; Zhong, J. Production of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans. J. Virol. 2011, 85, 2138–2147. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 2138-2147
-
-
Li, R.1
Qin, Y.2
He, Y.3
Tao, W.4
Zhang, N.5
Tsai, C.6
Zhou, P.7
Zhong, J.8
-
19
-
-
84897761072
-
Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles
-
[CrossRef] [PubMed]
-
Doerrbecker, J.; Friesland, M.; Riebesehl, N.; Ginkel, C.; Behrendt, P.; Brown, R.J.; Ciesek, S.; Wedemeyer, H.; Sarrazin, C.; Kaderali, L., et al. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles. Hepatology 2014, 60, 508–520. [CrossRef] [PubMed]
-
(2014)
Hepatology
, vol.60
, pp. 508-520
-
-
Doerrbecker, J.1
Friesland, M.2
Riebesehl, N.3
Ginkel, C.4
Behrendt, P.5
Brown, R.J.6
Ciesek, S.7
Wedemeyer, H.8
Sarrazin, C.9
Kaderali, L.10
-
20
-
-
84876207857
-
Natural selection of adaptive mutations in non-structural genes increases trans-encapsidation of hepatitis C virus replicons lacking envelope protein genes
-
[CrossRef] [PubMed]
-
Fournier, C.; Helle, F.; Descamps, V.; Morel, V.; Francois, C.; Dedeurwaerder, S.; Wychowski, C.; Duverlie, G.; Castelain, S. Natural selection of adaptive mutations in non-structural genes increases trans-encapsidation of hepatitis C virus replicons lacking envelope protein genes. J. Gen. Virol. 2013, 94, 996–1008. [CrossRef] [PubMed]
-
(2013)
J. Gen. Virol
, vol.94
, pp. 996-1008
-
-
Fournier, C.1
Helle, F.2
Descamps, V.3
Morel, V.4
Francois, C.5
Dedeurwaerder, S.6
Wychowski, C.7
Duverlie, G.8
Castelain, S.9
-
21
-
-
65549147626
-
Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA
-
[CrossRef] [PubMed]
-
Adair, R.; Patel, A.H.; Corless, L.; Griffin, S.; Rowlands, D.J.; McCormick, C.J. Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA. J. Gen. Virol. 2009, 90, 833–842. [CrossRef] [PubMed]
-
(2009)
J. Gen. Virol
, vol.90
, pp. 833-842
-
-
Adair, R.1
Patel, A.H.2
Corless, L.3
Griffin, S.4
Rowlands, D.J.5
McCormick, C.J.6
-
22
-
-
47049115607
-
Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles
-
[CrossRef] [PubMed]
-
Steinmann, E.; Brohm, C.; Kallis, S.; Bartenschlager, R.; Pietschmann, T. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J. Virol. 2008, 82, 7034–7046. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 7034-7046
-
-
Steinmann, E.1
Brohm, C.2
Kallis, S.3
Bartenschlager, R.4
Pietschmann, T.5
-
23
-
-
26244462660
-
Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer
-
[CrossRef] [PubMed]
-
Ciczora, Y.; Callens, N.; Montpellier, C.; Bartosch, B.; Cosset, F.L.; Op de Beeck, A.; Dubuisson, J. Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. J. Gen. Virol. 2005, 86, 2793–2798. [CrossRef] [PubMed]
-
(2005)
J. Gen. Virol
, vol.86
, pp. 2793-2798
-
-
Ciczora, Y.1
Callens, N.2
Montpellier, C.3
Bartosch, B.4
Cosset, F.L.5
De Op Beeck, A.6
Dubuisson, J.7
-
24
-
-
0031911782
-
A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2
-
[PubMed]
-
Cocquerel, L.; Meunier, J.C.; Pillez, A.; Wychowski, C.; Dubuisson, J. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J. Virol. 1998, 72, 2183–2191. [PubMed]
-
(1998)
J. Virol
, vol.72
, pp. 2183-2191
-
-
Cocquerel, L.1
Meunier, J.C.2
Pillez, A.3
Wychowski, C.4
Dubuisson, J.5
-
25
-
-
33847175190
-
Transmembrane domains of hepatitis C virus envelope glycoproteins: Residues involved in E1E2 heterodimerization and involvement of these domains in virus entry
-
[CrossRef] [PubMed]
-
Ciczora, Y.; Callens, N.; Penin, F.; Pecheur, E.I.; Dubuisson, J. Transmembrane domains of hepatitis C virus envelope glycoproteins: Residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. J. Virol. 2007, 81, 2372–2381. [CrossRef] [PubMed]
-
(2007)
J. Virol
, vol.81
, pp. 2372-2381
-
-
Ciczora, Y.1
Callens, N.2
Penin, F.3
Pecheur, E.I.4
Dubuisson, J.5
-
26
-
-
0040211559
-
The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization
-
[CrossRef] [PubMed]
-
Op de Beeck, A.; Montserret, R.; Duvet, S.; Cocquerel, L.; Cacan, R.; Barberot, B.; Le Maire, M.; Penin, F.; Dubuisson, J. The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. J. Biol. Chem. 2000, 275, 31428–31437. [CrossRef] [PubMed]
-
(2000)
J. Biol. Chem
, vol.275
, pp. 31428-31437
-
-
De Op Beeck, A.1
Montserret, R.2
Duvet, S.3
Cocquerel, L.4
Cacan, R.5
Barberot, B.6
Le Maire, M.7
Penin, F.8
Dubuisson, J.9
-
27
-
-
84896689860
-
Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry
-
[CrossRef] [PubMed]
-
Douam, F.; Dao Thi, V.L.; Maurin, G.; Fresquet, J.; Mompelat, D.; Zeisel, M.B.; Baumert, T.F.; Cosset, F.L.; Lavillette, D. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry. Hepatology 2014, 59, 776–788. [CrossRef] [PubMed]
-
(2014)
Hepatology
, vol.59
, pp. 776-788
-
-
Douam, F.1
Dao Thi, V.L.2
Maurin, G.3
Fresquet, J.4
Mompelat, D.5
Zeisel, M.B.6
Baumert, T.F.7
Cosset, F.L.8
Lavillette, D.9
-
28
-
-
0032898289
-
Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex
-
[PubMed]
-
Meunier, J.C.; Fournillier, A.; Choukhi, A.; Cahour, A.; Cocquerel, L.; Dubuisson, J.; Wychowski, C. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J. Gen. Virol. 1999, 80, 887–896. [PubMed]
-
(1999)
J. Gen. Virol
, vol.80
, pp. 887-896
-
-
Meunier, J.C.1
Fournillier, A.2
Choukhi, A.3
Cahour, A.4
Cocquerel, L.5
Dubuisson, J.6
Wychowski, C.7
-
29
-
-
20744441154
-
Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins
-
[CrossRef] [PubMed]
-
Goffard, A.; Callens, N.; Bartosch, B.; Wychowski, C.; Cosset, F.L.; Montpellier, C.; Dubuisson, J. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J. Virol. 2005, 79, 8400–8409. [CrossRef] [PubMed]
-
(2005)
J. Virol
, vol.79
, pp. 8400-8409
-
-
Goffard, A.1
Callens, N.2
Bartosch, B.3
Wychowski, C.4
Cosset, F.L.5
Montpellier, C.6
Dubuisson, J.7
-
30
-
-
79953210378
-
Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry
-
[CrossRef] [PubMed]
-
Brown, K.S.; Keogh, M.J.; Owsianka, A.M.; Adair, R.; Patel, A.H.; Arnold, J.N.; Ball, J.K.; Sim, R.B.; Tarr, A.W.; Hickling, T.P. Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry. Protein Cell 2010, 1, 664–674. [CrossRef] [PubMed]
-
(2010)
Protein Cell
, vol.1
, pp. 664-674
-
-
Brown, K.S.1
Keogh, M.J.2
Owsianka, A.M.3
Adair, R.4
Patel, A.H.5
Arnold, J.N.6
Ball, J.K.7
Sim, R.B.8
Tarr, A.W.9
Hickling, T.P.10
-
31
-
-
84861313031
-
Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function
-
[CrossRef] [PubMed]
-
McCaffrey, K.; Boo, I.; Tewierek, K.; Edmunds, M.L.; Poumbourios, P.; Drummer, H.E. Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function. J. Virol. 2012, 86, 3961–3974. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 3961-3974
-
-
McCaffrey, K.1
Boo, I.2
Tewierek, K.3
Edmunds, M.L.4
Poumbourios, P.5
Drummer, H.E.6
-
32
-
-
84873043530
-
Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein
-
[CrossRef] [PubMed]
-
Wahid, A.; Helle, F.; Descamps, V.; Duverlie, G.; Penin, F.; Dubuisson, J. Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein. J. Virol. 2013, 87, 1605–1617. [CrossRef] [PubMed]
-
(2013)
J. Virol
, vol.87
, pp. 1605-1617
-
-
Wahid, A.1
Helle, F.2
Descamps, V.3
Duverlie, G.4
Penin, F.5
Dubuisson, J.6
-
33
-
-
84908010481
-
Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins
-
[CrossRef] [PubMed]
-
Lee, J.Y.; Acosta, E.G.; Stoeck, I.K.; Long, G.; Hiet, M.S.; Mueller, B.; Fackler, O.T.; Kallis, S.; Bartenschlager, R. Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins. J. Virol. 2014, 88, 12422–12437. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 12422-12437
-
-
Lee, J.Y.1
Acosta, E.G.2
Stoeck, I.K.3
Long, G.4
Hiet, M.S.5
Mueller, B.6
Fackler, O.T.7
Kallis, S.8
Bartenschlager, R.9
-
34
-
-
12344290099
-
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells
-
[CrossRef] [PubMed]
-
Brazzoli, M.; Helenius, A.; Foung, S.K.; Houghton, M.; Abrignani, S.; Merola, M. Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells. Virology 2005, 332, 438–453. [CrossRef] [PubMed]
-
(2005)
Virology
, vol.332
, pp. 438-453
-
-
Brazzoli, M.1
Helenius, A.2
Foung, S.K.3
Houghton, M.4
Abrignani, S.5
Merola, M.6
-
35
-
-
22544470874
-
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
-
[CrossRef] [PubMed]
-
Wakita, T.; Pietschmann, T.; Kato, T.; Date, T.; Miyamoto, M.; Zhao, Z.; Murthy, K.; Habermann, A.; Krausslich, H.G.; Mizokami, M., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11, 791–796. [CrossRef] [PubMed]
-
(2005)
Nat. Med
, vol.11
, pp. 791-796
-
-
Wakita, T.1
Pietschmann, T.2
Kato, T.3
Date, T.4
Miyamoto, M.5
Zhao, Z.6
Murthy, K.7
Habermann, A.8
Krausslich, H.G.9
Mizokami, M.10
-
36
-
-
28044468402
-
Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularlyand requires concomitant incorporation of E1 and E2 glycoproteins
-
[CrossRef] [PubMed]
-
Sandrin, V.; Boulanger, P.; Penin, F.; Granier, C.; Cosset, F.L.; Bartosch, B. Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. J. Gen. Virol. 2005, 86, 3189–3199. [CrossRef] [PubMed]
-
(2005)
J. Gen. Virol
, vol.86
, pp. 3189-3199
-
-
Sandrin, V.1
Boulanger, P.2
Penin, F.3
Granier, C.4
Cosset, F.L.5
Bartosch, B.6
-
37
-
-
0034663695
-
A model for the hepatitis C virus envelope glycoprotein E2
-
[CrossRef]
-
Yagnik, A.T.; Lahm, A.; Meola, A.; Roccasecca, R.M.; Ercole, B.B.; Nicosia, A.; Tramontano, A. A model for the hepatitis C virus envelope glycoprotein E2. Proteins 2000, 40, 355–366. [CrossRef]
-
(2000)
Proteins
, vol.40
, pp. 355-366
-
-
Yagnik, A.T.1
Lahm, A.2
Meola, A.3
Roccasecca, R.M.4
Ercole, B.B.5
Nicosia, A.6
Tramontano, A.7
-
38
-
-
0032813509
-
Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein
-
[PubMed]
-
Flint, M.; Thomas, J.M.; Maidens, C.M.; Shotton, C.; Levy, S.; Barclay, W.S.; McKeating, J.A. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J. Virol. 1999, 73, 6782–6790. [PubMed]
-
(1999)
J. Virol
, vol.73
, pp. 6782-6790
-
-
Flint, M.1
Thomas, J.M.2
Maidens, C.M.3
Shotton, C.4
Levy, S.5
Barclay, W.S.6
McKeating, J.A.7
-
39
-
-
0037495036
-
Ligand-binding pocket in the dengue virus envelope glycoprotein
-
[CrossRef] [PubMed]
-
Modis, Y.; Ogata, S.; Clements, D.; Harrison, S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 2003, 100, 6986–6991. [CrossRef] [PubMed]
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 6986-6991
-
-
Modis, Y.1
Ogata, S.2
Clements, D.3
Harrison, S.4
-
40
-
-
1642499388
-
Structure of the dengue virus envelope protein after membrane fusion
-
[CrossRef] [PubMed]
-
Modis, Y.; Ogata, S.; Clements, D.; Harrison, S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427, 313–319. [CrossRef] [PubMed]
-
(2004)
Nature
, vol.427
, pp. 313-319
-
-
Modis, Y.1
Ogata, S.2
Clements, D.3
Harrison, S.C.4
-
41
-
-
77649269513
-
The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule
-
[CrossRef] [PubMed]
-
Krey, T.; d’Alayer, J.; Kikuti, C.M.; Saulnier, A.; Damier-Piolle, L.; Petitpas, I.; Johansson, D.X.; Tawar, R.G.; Baron, B.; Robert, B., et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog. 2010, 6, e1000762. [CrossRef] [PubMed]
-
(2010)
Plos Pathog
, vol.6
-
-
Krey, T.1
D’Alayer, J.2
Kikuti, C.M.3
Saulnier, A.4
Damier-Piolle, L.5
Petitpas, I.6
Johansson, D.X.7
Tawar, R.G.8
Baron, B.9
Robert, B.E.10
-
42
-
-
84888778890
-
Hepatitis C virus E2 envelope glycoprotein core structure
-
[CrossRef] [PubMed]
-
Kong, L.; Giang, E.; Nieusma, T.; Kadam, R.U.; Cogburn, K.E.; Hua, Y.; Dai, X.; Stanfield, R.L.; Burton, D.R.; Ward, A.B., et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science 2013, 342, 1090–1094. [CrossRef] [PubMed]
-
(2013)
Science
, vol.342
, pp. 1090-1094
-
-
Kong, L.1
Giang, E.2
Nieusma, T.3
Kadam, R.U.4
Cogburn, K.E.5
Hua, Y.6
Dai, X.7
Stanfield, R.L.8
Burton, D.R.9
Ward, A.B.10
-
43
-
-
70349973419
-
Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: Involvement in cell fusion and virus entry
-
[CrossRef] [PubMed]
-
Li, H.F.; Huang, C.H.; Ai, L.S.; Chuang, C.K.; Chen, S.S. Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: Involvement in cell fusion and virus entry. J. Biomed. Sci. 2009, 16, e89. [CrossRef] [PubMed]
-
(2009)
J. Biomed. Sci
, vol.16
-
-
Li, H.F.1
Huang, C.H.2
Ai, L.S.3
Chuang, C.K.4
Chen, S.S.5
-
44
-
-
34047137160
-
Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1
-
[CrossRef] [PubMed]
-
Drummer, H.E.; Boo, I.; Poumbourios, P. Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. J. Gen. Virol. 2007, 88, 1144–1148. [CrossRef] [PubMed]
-
(2007)
J. Gen. Virol
, vol.88
, pp. 1144-1148
-
-
Drummer, H.E.1
Boo, I.2
Poumbourios, P.3
-
45
-
-
76749170398
-
Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein. Biochim
-
[CrossRef] [PubMed]
-
Spadaccini, R.; D’Errico, G.; D’Alessio, V.; Notomista, E.; Bianchi, A.; Merola, M.; Picone, D. Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein. Biochim. Biophys. Acta 2010, 1798, 344–353. [CrossRef] [PubMed]
-
(2010)
Biophys. Acta
, vol.1798
, pp. 344-353
-
-
Spadaccini, R.1
D’Errico, G.2
D’Alessio, V.3
Notomista, E.4
Bianchi, A.5
Merola, M.6
Picone, D.7
-
46
-
-
68949209321
-
Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles
-
[CrossRef] [PubMed]
-
Russell, R.S.; Kawaguchi, K.; Meunier, J.C.; Takikawa, S.; Faulk, K.; Bukh, J.; Purcell, R.H.; Emerson, S.U. Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles. J. Viral Hepat. 2009, 16, 621–632. [CrossRef] [PubMed]
-
(2009)
J. Viral Hepat
, vol.16
, pp. 621-632
-
-
Russell, R.S.1
Kawaguchi, K.2
Meunier, J.C.3
Takikawa, S.4
Faulk, K.5
Bukh, J.6
Purcell, R.H.7
Emerson, S.U.8
-
47
-
-
84876865608
-
Crystal structure of glycoprotein E2 from bovine viral diarrhea virus
-
[CrossRef] [PubMed]
-
Li, Y.; Wang, J.; Kanai, R.; Modis, Y. Crystal structure of glycoprotein E2 from bovine viral diarrhea virus. Proc. Natl. Acad. Sci. USA 2013, 110, 6805–6810. [CrossRef] [PubMed]
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 6805-6810
-
-
Li, Y.1
Wang, J.2
Kanai, R.3
Modis, Y.4
-
48
-
-
84873133718
-
Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry
-
[CrossRef] [PubMed]
-
El Omari, K.; Iourin, O.; Harlos, K.; Grimes, J.M.; Stuart, D.I. Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry. Cell Rep. 2013, 3, 30–35. [CrossRef] [PubMed]
-
(2013)
Cell Rep
, vol.3
, pp. 30-35
-
-
El Omari, K.1
Iourin, O.2
Harlos, K.3
Grimes, J.M.4
Stuart, D.I.5
-
49
-
-
84900798422
-
Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2
-
[CrossRef] [PubMed]
-
Khan, A.G.; Whidby, J.; Miller, M.T.; Scarborough, H.; Zatorski, A.V.; Cygan, A.; Price, A.A.; Yost, S.A.; Bohannon, C.D.; Jacob, J., et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 2014, 509, 381–384. [CrossRef] [PubMed]
-
(2014)
Nature
, vol.509
, pp. 381-384
-
-
Khan, A.G.1
Whidby, J.2
Miller, M.T.3
Scarborough, H.4
Zatorski, A.V.5
Cygan, A.6
Price, A.A.7
Yost, S.A.8
Bohannon, C.D.9
Jacob, J.10
-
50
-
-
84878685870
-
Ultrastructural analysis of hepatitis C virus particles
-
[CrossRef] [PubMed]
-
Catanese, M.T.; Uryu, K.; Kopp, M.; Edwards, T.J.; Andrus, L.; Rice, W.J.; Silvestry, M.; Kuhn, R.J.; Rice, C.M. Ultrastructural analysis of hepatitis C virus particles. Proc. Natl. Acad. Sci. USA 2013, 110, 9505–9510. [CrossRef] [PubMed]
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 9505-9510
-
-
Catanese, M.T.1
Uryu, K.2
Kopp, M.3
Edwards, T.J.4
Andrus, L.5
Rice, W.J.6
Silvestry, M.7
Kuhn, R.J.8
Rice, C.M.9
-
51
-
-
77957933124
-
Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture
-
[CrossRef] [PubMed]
-
Gastaminza, P.; Dryden, K.A.; Boyd, B.; Wood, M.R.; Law, M.; Yeager, M.; Chisari, F.V. Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. J. Virol. 2010, 84, 10999–11009. [CrossRef] [PubMed]
-
(2010)
J. Virol
, vol.84
, pp. 10999-11009
-
-
Gastaminza, P.1
Dryden, K.A.2
Boyd, B.3
Wood, M.R.4
Law, M.5
Yeager, M.6
Chisari, F.V.7
-
52
-
-
33748673151
-
Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding
-
[CrossRef] [PubMed]
-
Owsianka, A.M.; Timms, J.M.; Tarr, A.W.; Brown, R.J.; Hickling, T.P.; Szwejk, A.; Bienkowska-Szewczyk, K.; Thomson, B.J.; Patel, A.H.; Ball, J.K. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J. Virol. 2006, 80, 8695–8704. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 8695-8704
-
-
Owsianka, A.M.1
Timms, J.M.2
Tarr, A.W.3
Brown, R.J.4
Hickling, T.P.5
Szwejk, A.6
Bienkowska-Szewczyk, K.7
Thomson, B.J.8
Patel, A.H.9
Ball, J.K.10
-
53
-
-
41549117544
-
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding
-
[CrossRef] [PubMed]
-
Rothwangl, K.B.; Manicassamy, B.; Uprichard, S.L.; Rong, L. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding. Virol. J. 2008, 5, e46. [CrossRef] [PubMed]
-
(2008)
Virol. J
, vol.5
-
-
Rothwangl, K.B.1
Manicassamy, B.2
Uprichard, S.L.3
Rong, L.4
-
54
-
-
84906342318
-
Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors
-
[CrossRef] [PubMed]
-
Lavie, M.; Sarrazin, S.; Montserret, R.; Descamps, V.; Baumert, T.F.; Duverlie, G.; Seron, K.; Penin, F.; Dubuisson, J. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors. J. Virol. 2014, 88, 10584–10597. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 10584-10597
-
-
Lavie, M.1
Sarrazin, S.2
Montserret, R.3
Descamps, V.4
Baumert, T.F.5
Duverlie, G.6
Seron, K.7
Penin, F.8
Dubuisson, J.9
-
55
-
-
77951990633
-
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes
-
[CrossRef] [PubMed]
-
Bankwitz, D.; Steinmann, E.; Bitzegeio, J.; Ciesek, S.; Friesland, M.; Herrmann, E.; Zeisel, M.B.; Baumert, T.F.; Keck, Z.Y.; Foung, S.K., et al. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J. Virol. 2010, 84, 5751–5763. [CrossRef] [PubMed]
-
(2010)
J. Virol
, vol.84
, pp. 5751-5763
-
-
Bankwitz, D.1
Steinmann, E.2
Bitzegeio, J.3
Ciesek, S.4
Friesland, M.5
Herrmann, E.6
Zeisel, M.B.7
Baumert, T.F.8
Keck, Z.Y.9
Foung, S.K.10
-
56
-
-
84907971360
-
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins
-
[CrossRef] [PubMed]
-
Bankwitz, D.; Vieyres, G.; Hueging, K.; Bitzegeio, J.; Doepke, M.; Chhatwal, P.; Haid, S.; Catanese, M.T.; Zeisel, M.B.; Nicosia, A., et al. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. J. Virol. 2014, 88, 12644–12655. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 12644-12655
-
-
Bankwitz, D.1
Vieyres, G.2
Hueging, K.3
Bitzegeio, J.4
Doepke, M.5
Chhatwal, P.6
Haid, S.7
Catanese, M.T.8
Zeisel, M.B.9
Nicosia, A.E.10
-
57
-
-
20744437263
-
An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies
-
[CrossRef] [PubMed]
-
Bartosch, B.; Verney, G.; Dreux, M.; Donot, P.; Morice, Y.; Penin, F.; Pawlotsky, J.M.; Lavillette, D.; Cosset, F.L. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J. Virol. 2005, 79, 8217–8229. [CrossRef] [PubMed]
-
(2005)
J. Virol
, vol.79
, pp. 8217-8229
-
-
Bartosch, B.1
Verney, G.2
Dreux, M.3
Donot, P.4
Morice, Y.5
Penin, F.6
Pawlotsky, J.M.7
Lavillette, D.8
Cosset, F.L.9
-
58
-
-
29744462734
-
Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry
-
[CrossRef] [PubMed]
-
Callens, N.; Ciczora, Y.; Bartosch, B.; Vu-Dac, N.; Cosset, F.L.; Pawlotsky, J.M.; Penin, F.; Dubuisson, J. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry. J. Virol. 2005, 79, 15331–15341. [CrossRef] [PubMed]
-
(2005)
J. Virol
, vol.79
, pp. 15331-15341
-
-
Callens, N.1
Ciczora, Y.2
Bartosch, B.3
Vu-Dac, N.4
Cosset, F.L.5
Pawlotsky, J.M.6
Penin, F.7
Dubuisson, J.8
-
59
-
-
84867427019
-
Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion
-
[CrossRef] [PubMed]
-
Guan, M.; Wang, W.; Liu, X.; Tong, Y.; Liu, Y.; Ren, H.; Zhu, S.; Dubuisson, J.; Baumert, T.F.; Zhu, Y., et al. Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion. J. Biol. Chem. 2012, 287, 35631–35645. [CrossRef] [PubMed]
-
(2012)
J. Biol. Chem
, vol.287
, pp. 35631-35645
-
-
Guan, M.1
Wang, W.2
Liu, X.3
Tong, Y.4
Liu, Y.5
Ren, H.6
Zhu, S.7
Dubuisson, J.8
Baumert, T.F.9
Zhu, Y.10
-
60
-
-
36248932655
-
Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33
-
[CrossRef] [PubMed]
-
Tarr, A.W.; Owsianka, A.M.; Jayaraj, D.; Brown, R.J.; Hickling, T.P.; Irving, W.L.; Patel, A.H.; Ball, J.K. Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33. J. Gen. Virol. 2007, 88, 2991–3001. [CrossRef] [PubMed]
-
(2007)
J. Gen. Virol
, vol.88
, pp. 2991-3001
-
-
Tarr, A.W.1
Owsianka, A.M.2
Jayaraj, D.3
Brown, R.J.4
Hickling, T.P.5
Irving, W.L.6
Patel, A.H.7
Ball, J.K.8
-
61
-
-
84863229503
-
Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization
-
[CrossRef] [PubMed]
-
Tarr, A.W.; Urbanowicz, R.A.; Jayaraj, D.; Brown, R.J.; McKeating, J.A.; Irving, W.L.; Ball, J.K. Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization. J. Virol. 2012, 86, 2739–2749. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 2739-2749
-
-
Tarr, A.W.1
Urbanowicz, R.A.2
Jayaraj, D.3
Brown, R.J.4
McKeating, J.A.5
Irving, W.L.6
Ball, J.K.7
-
62
-
-
84921684956
-
Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein e2 recognized by broadly neutralizing antibodies
-
[CrossRef] [PubMed]
-
Meola, A.; Tarr, A.W.; England, P.; Meredith, L.W.; McClure, C.P.; Foung, S.K.; McKeating, J.A.; Ball, J.K.; Rey, F.A.; Krey, T. Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein e2 recognized by broadly neutralizing antibodies. J. Virol. 2015, 89, 2170–2181. [CrossRef] [PubMed]
-
(2015)
J. Virol
, vol.89
, pp. 2170-2181
-
-
Meola, A.1
Tarr, A.W.2
England, P.3
Meredith, L.W.4
McClure, C.P.5
Foung, S.K.6
McKeating, J.A.7
Ball, J.K.8
Rey, F.A.9
Krey, T.10
-
63
-
-
84869233037
-
Virus vaccine: The structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody
-
[CrossRef] [PubMed]
-
Potter, J.A.; Owsianka, A.M.; Jeffery, N.; Matthews, D.J.; Keck, Z.Y.; Lau, P.; Foung, S.K.; Taylor, G.L.; Patel, A.H. Toward a hepatitis C virus vaccine: The structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody. J. Virol. 2012, 86, 12923–12932. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 12923-12932
-
-
Potter, J.A.1
Owsianka, A.M.2
Jeffery, N.3
Matthews, D.J.4
Keck, Z.Y.5
Lau, P.6
Foung, S.K.7
Taylor, G.L.8
Patel, A.H.9
Toward A Hepatitis, C.10
-
64
-
-
84869229723
-
Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33
-
[CrossRef] [PubMed]
-
Kong, L.; Giang, E.; Nieusma, T.; Robbins, J.B.; Deller, M.C.; Stanfield, R.L.; Wilson, I.A.; Law, M. Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33. J. Virol. 2012, 86, 13085–13088. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 13085-13088
-
-
Kong, L.1
Giang, E.2
Nieusma, T.3
Robbins, J.B.4
Deller, M.C.5
Stanfield, R.L.6
Wilson, I.A.7
Law, M.8
-
65
-
-
84862177880
-
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
-
[CrossRef] [PubMed]
-
Kong, L.; Giang, E.; Robbins, J.B.; Stanfield, R.L.; Burton, D.R.; Wilson, I.A.; Law, M. Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proc. Natl. Acad. Sci. USA 2012, 109, 9499–9504. [CrossRef] [PubMed]
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 9499-9504
-
-
Kong, L.1
Giang, E.2
Robbins, J.B.3
Stanfield, R.L.4
Burton, D.R.5
Wilson, I.A.6
Law, M.7
-
66
-
-
84927920900
-
Structural basis for penetration of the glycan shield of hepatitis c virus e2 glycoprotein by a broadly neutralizing human antibody
-
[CrossRef] [PubMed]
-
Li, Y.; Pierce, B.G.; Wang, Q.; Keck, Z.Y.; Fuerst, T.R.; Foung, S.K.; Mariuzza, R.A. Structural basis for penetration of the glycan shield of hepatitis c virus e2 glycoprotein by a broadly neutralizing human antibody. J. Biol. Chem. 2015, 290, 10117–10125. [CrossRef] [PubMed]
-
(2015)
J. Biol. Chem
, vol.290
, pp. 10117-10125
-
-
Li, Y.1
Pierce, B.G.2
Wang, Q.3
Keck, Z.Y.4
Fuerst, T.R.5
Foung, S.K.6
Mariuzza, R.A.7
-
67
-
-
0029014434
-
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution
-
[CrossRef] [PubMed]
-
Rey, F.A.; Heinz, F.X.; Mandl, C.; Kunz, C.; Harrison, S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995, 375, 291–298. [CrossRef] [PubMed]
-
(1995)
Nature
, vol.375
, pp. 291-298
-
-
Rey, F.A.1
Heinz, F.X.2
Mandl, C.3
Kunz, C.4
Harrison, S.C.5
-
68
-
-
0029897920
-
Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells
-
[CrossRef] [PubMed]
-
Fournillier Jacob, A.; Cahour, A.; Escriou, N.; Girard, M.; Wychowski, C. Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells. J. Gen. Virol. 1996, 77, 1055–1064. [CrossRef] [PubMed]
-
(1996)
J. Gen. Virol
, vol.77
, pp. 1055-1064
-
-
Fournillier Jacob, A.1
Cahour, A.2
Escriou, N.3
Girard, M.4
Wychowski, C.5
-
69
-
-
0032505543
-
Hepatitis C virus E1 protein induces modification of membrane permeability in
-
[CrossRef] [PubMed]
-
Ciccaglione, A.R.; Marcantonio, C.; Costantino, A.; Equestre, M.; Geraci, A.; Rapicetta, M. Hepatitis C virus E1 protein induces modification of membrane permeability in E. coli cells. Virology 1998, 250, 1–8. [CrossRef] [PubMed]
-
(1998)
E. Coli Cells. Virology
, vol.250
, pp. 1-8
-
-
Ciccaglione, A.R.1
Marcantonio, C.2
Costantino, A.3
Equestre, M.4
Geraci, A.5
Rapicetta, M.6
-
70
-
-
0034766232
-
Folding of hepatitis C virus E1 glycoprotein in a cell-free system
-
[CrossRef] [PubMed]
-
Merola, M.; Brazzoli, M.; Cocchiarella, F.; Heile, J.M.; Helenius, A.; Weiner, A.J.; Houghton, M.; Abrignani, S. Folding of hepatitis C virus E1 glycoprotein in a cell-free system. J. Virol. 2001, 75, 11205–11217. [CrossRef] [PubMed]
-
(2001)
J. Virol
, vol.75
, pp. 11205-11217
-
-
Merola, M.1
Brazzoli, M.2
Cocchiarella, F.3
Heile, J.M.4
Helenius, A.5
Weiner, A.J.6
Houghton, M.7
Abrignani, S.8
-
71
-
-
84923348810
-
Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1. Nat
-
[CrossRef] [PubMed]
-
El Omari, K.; Iourin, O.; Kadlec, J.; Sutton, G.; Harlos, K.; Grimes, J.M.; Stuart, D.I. Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1. Nat. Commun. 2014, 5, e4874. [CrossRef] [PubMed]
-
(2014)
Commun
, vol.5
-
-
El Omari, K.1
Iourin, O.2
Kadlec, J.3
Sutton, G.4
Harlos, K.5
Grimes, J.M.6
Stuart, D.I.7
-
72
-
-
84865130203
-
Application of next-generation sequencing technologies in virology
-
[CrossRef] [PubMed]
-
Radford, A.D.; Chapman, D.; Dixon, L.; Chantrey, J.; Darby, A.C.; Hall, N. Application of next-generation sequencing technologies in virology. J. Gen. Virol. 2012, 93, 1853–1868. [CrossRef] [PubMed]
-
(2012)
J. Gen. Virol
, vol.93
, pp. 1853-1868
-
-
Radford, A.D.1
Chapman, D.2
Dixon, L.3
Chantrey, J.4
Darby, A.C.5
Hall, N.6
-
73
-
-
84926435481
-
A public health approach to hepatitis C control in low- and middle-income countries
-
[CrossRef] [PubMed]
-
Suthar, A.B.; Harries, A.D. A public health approach to hepatitis C control in low- and middle-income countries. PLoS Med. 2015, 12, e1001795. [CrossRef] [PubMed]
-
(2015)
Plos Med
, vol.12
-
-
Suthar, A.B.1
Harries, A.D.2
-
74
-
-
79961216296
-
Virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes
-
[CrossRef] [PubMed]
-
Mazumdar, B.; Banerjee, A.; Meyer, K.; Ray, R. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology 2011, 54, 1149–1156. [CrossRef] [PubMed]
-
(2011)
Hepatology
, vol.54
, pp. 1149-1156
-
-
Mazumdar, B.1
Banerjee, A.2
Meyer, K.3
Ray, R.4
Hepatitis, C.5
-
75
-
-
57349129441
-
Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies
-
[CrossRef] [PubMed]
-
Grove, J.; Nielsen, S.; Zhong, J.; Bassendine, M.F.; Drummer, H.E.; Balfe, P.; McKeating, J.A. Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J. Virol. 2008, 82, 12020–12029. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 12020-12029
-
-
Grove, J.1
Nielsen, S.2
Zhong, J.3
Bassendine, M.F.4
Drummer, H.E.5
Balfe, P.6
McKeating, J.A.7
-
76
-
-
33746792754
-
A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry
-
[CrossRef] [PubMed]
-
Drummer, H.E.; Boo, I.; Maerz, A.L.; Poumbourios, P. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry. J. Virol. 2006, 80, 7844–7853. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 7844-7853
-
-
Drummer, H.E.1
Boo, I.2
Maerz, A.L.3
Poumbourios, P.4
-
77
-
-
33846813697
-
Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes
-
[CrossRef] [PubMed]
-
Brown, R.J.; Tarr, A.W.; McClure, C.P.; Juttla, V.S.; Tagiuri, N.; Irving, W.L.; Ball, J.K. Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes. J. Gen. Virol. 2007, 88, 458–469. [CrossRef] [PubMed]
-
(2007)
J. Gen. Virol
, vol.88
, pp. 458-469
-
-
Brown, R.J.1
Tarr, A.W.2
McClure, C.P.3
Juttla, V.S.4
Tagiuri, N.5
Irving, W.L.6
Ball, J.K.7
-
78
-
-
23044437222
-
Complete replication of hepatitis C virus in cell culture
-
[CrossRef] [PubMed]
-
Lindenbach, B.D.; Evans, M.J.; Syder, A.J.; Wolk, B.; Tellinghuisen, T.L.; Liu, C.C.; Maruyama, T.; Hynes, R.O.; Burton, D.R.; McKeating, J.A., et al. Complete replication of hepatitis C virus in cell culture. Science 2005, 309, 623–626. [CrossRef] [PubMed]
-
(2005)
Science
, vol.309
, pp. 623-626
-
-
Lindenbach, B.D.1
Evans, M.J.2
Syder, A.J.3
Wolk, B.4
Tellinghuisen, T.L.5
Liu, C.C.6
Maruyama, T.7
Hynes, R.O.8
Burton, D.R.9
McKeating, J.A.10
-
79
-
-
25844523297
-
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
-
[CrossRef] [PubMed]
-
Simmonds, P.; Bukh, J.; Combet, C.; Deleage, G.; Enomoto, N.; Feinstone, S.; Halfon, P.; Inchauspe, G.; Kuiken, C.; Maertens, G., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42, 962–973. [CrossRef] [PubMed]
-
(2005)
Hepatology
, vol.42
, pp. 962-973
-
-
Simmonds, P.1
Bukh, J.2
Combet, C.3
Deleage, G.4
Enomoto, N.5
Feinstone, S.6
Halfon, P.7
Inchauspe, G.8
Kuiken, C.9
Maertens, G.10
-
80
-
-
84894707183
-
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
-
[CrossRef] [PubMed]
-
Smith, D.B.; Bukh, J.; Kuiken, C.; Muerhoff, A.S.; Rice, C.M.; Stapleton, J.T.; Simmonds, P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource. Hepatology 2014, 59, 318–327. [CrossRef] [PubMed]
-
(2014)
Hepatology
, vol.59
, pp. 318-327
-
-
Smith, D.B.1
Bukh, J.2
Kuiken, C.3
Muerhoff, A.S.4
Rice, C.M.5
Stapleton, J.T.6
Simmonds, P.7
-
81
-
-
79958788949
-
Introduction: A smouldering public-health crisis
-
[CrossRef] [PubMed]
-
Gravitz, L. Introduction: A smouldering public-health crisis. Nature 2011, 474, S2–S4. [CrossRef] [PubMed]
-
(2011)
Nature
, vol.474
-
-
Gravitz, L.1
-
82
-
-
84921060015
-
Global distribution and prevalence of hepatitis C virus genotypes
-
[CrossRef] [PubMed]
-
Messina, J.P.; Humphreys, I.; Flaxman, A.; Brown, A.; Cooke, G.S.; Pybus, O.G.; Barnes, E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015, 61, 77–87. [CrossRef] [PubMed]
-
(2015)
Hepatology
, vol.61
, pp. 77-87
-
-
Messina, J.P.1
Humphreys, I.2
Flaxman, A.3
Brown, A.4
Cooke, G.S.5
Pybus, O.G.6
Barnes, E.7
-
83
-
-
34250679750
-
Epidemiology of hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Alter, M.J. Epidemiology of hepatitis C virus infection. World J. Gastroenterol. 2007, 13, 2436–2441. [CrossRef] [PubMed]
-
(2007)
World J. Gastroenterol
, vol.13
, pp. 2436-2441
-
-
Alter, M.J.1
-
84
-
-
74049120411
-
The global spread of hepatitis C virus 1a and 1b: A phylodynamic and phylogeographic analysis
-
[CrossRef] [PubMed]
-
Magiorkinis, G.; Magiorkinis, E.; Paraskevis, D.; Ho, S.Y.; Shapiro, B.; Pybus, O.G.; Allain, J.P.; Hatzakis, A. The global spread of hepatitis C virus 1a and 1b: A phylodynamic and phylogeographic analysis. PLoS Med. 2009, 6, e1000198. [CrossRef] [PubMed]
-
(2009)
Plos Med
, vol.6
-
-
Magiorkinis, G.1
Magiorkinis, E.2
Paraskevis, D.3
Ho, S.Y.4
Shapiro, B.5
Pybus, O.G.6
Allain, J.P.7
Hatzakis, A.8
-
85
-
-
0035933522
-
The epidemic behavior of the hepatitis C virus
-
[CrossRef] [PubMed]
-
Pybus, O.G.; Charleston, M.A.; Gupta, S.; Rambaut, A.; Holmes, E.C.; Harvey, P.H. The epidemic behavior of the hepatitis C virus. Science 2001, 292, 2323–2325. [CrossRef] [PubMed]
-
(2001)
Science
, vol.292
, pp. 2323-2325
-
-
Pybus, O.G.1
Charleston, M.A.2
Gupta, S.3
Rambaut, A.4
Holmes, E.C.5
Harvey, P.H.6
-
86
-
-
67650236561
-
What are the prospects for controlling hepatitis C?
-
[CrossRef] [PubMed]
-
Klenerman, P.; Fleming, V.; Barnes, E. What are the prospects for controlling hepatitis C? PLoS Med. 2009, 6, e1000096. [CrossRef] [PubMed]
-
(2009)
Plos Med
, vol.6
-
-
Klenerman, P.1
Fleming, V.2
Barnes, E.3
-
87
-
-
7444256169
-
Genetic diversity and evolution of hepatitis C virus—15 years on
-
[CrossRef] [PubMed]
-
Simmonds, P. Genetic diversity and evolution of hepatitis C virus—15 years on. J. Gen. Virol. 2004, 85, 3173–3188. [CrossRef] [PubMed]
-
(2004)
J. Gen. Virol
, vol.85
, pp. 3173-3188
-
-
Simmonds, P.1
-
88
-
-
84890870335
-
Analysis of serine codon conservationreveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution
-
[CrossRef] [PubMed]
-
Brown, R.J.; Koutsoudakis, G.; Urbanowicz, R.A.; Mirza, D.; Ginkel, C.; Riebesehl, N.; Calland, N.; Albecka, A.; Price, L.; Hudson, N., et al. Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution. J. Virol. 2014, 88, 667–678. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 667-678
-
-
Brown, R.J.1
Koutsoudakis, G.2
Urbanowicz, R.A.3
Mirza, D.4
Ginkel, C.5
Riebesehl, N.6
Calland, N.7
Albecka, A.8
Price, L.9
Hudson, N.10
-
89
-
-
84861108064
-
Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome
-
[CrossRef] [PubMed]
-
Munshaw, S.; Bailey, J.R.; Liu, L.; Osburn, W.O.; Burke, K.P.; Cox, A.L.; Ray, S.C. Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome. J. Virol. 2012, 86, 5915–5921. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 5915-5921
-
-
Munshaw, S.1
Bailey, J.R.2
Liu, L.3
Osburn, W.O.4
Burke, K.P.5
Cox, A.L.6
Ray, S.C.7
-
90
-
-
84861161553
-
Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Burke, L.P.; Munshaw, S.; Osburn, W.O.; Levine, J.; Liu, L.; Sidney, J.; Sette, A.; Ray, S.C.; Cox, A.L. Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection. J. Immunol. 2012, 5177–5188. [CrossRef] [PubMed]
-
(2012)
J. Immunol
, pp. 5177-5188
-
-
Burke, L.P.1
Munshaw, S.2
Osburn, W.O.3
Levine, J.4
Liu, L.5
Sidney, J.6
Sette, A.7
Ray, S.C.8
Cox, A.L.9
-
91
-
-
41949124934
-
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing
-
[CrossRef] [PubMed]
-
Salazar-Gonzalez, J.F.; Bailes, E.; Pham, K.T.; Salazar, M.G.; Guffey, M.B.; Keele, B.F.; Derdeyn, C.A.; Farmer, P.; Hunter, E.; Allen, S., et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 2008, 82, 3952–3970. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 3952-3970
-
-
Salazar-Gonzalez, J.F.1
Bailes, E.2
Pham, K.T.3
Salazar, M.G.4
Guffey, M.B.5
Keele, B.F.6
Derdeyn, C.A.7
Farmer, P.8
Hunter, E.9
Allen, S.10
-
92
-
-
77952709675
-
Virus transmission bottlenecks analyzed by deep sequencing
-
[CrossRef] [PubMed]
-
Wang, G.P.; Sherrill-Mix, S.A.; Chang, K.M.; Quince, C.; Bushman, F.D. Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. J. Virol. 2010, 84, 6218–6228. [CrossRef] [PubMed]
-
(2010)
J. Virol
, vol.84
, pp. 6218-6228
-
-
Wang, G.P.1
Sherrill-Mix, S.A.2
Chang, K.M.3
Quince, C.4
Bushman, F.D.5
Hepatitis, C.6
-
93
-
-
15244353559
-
Wide range of quasispecies diversity during primary hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Herring, B.L.; Tsui, R.; Peddada, L.; Busch, M.; Delwart, E.L. Wide range of quasispecies diversity during primary hepatitis C virus infection. J. Virol. 2005, 79, 4340–4346. [CrossRef] [PubMed]
-
(2005)
J. Virol
, vol.79
, pp. 4340-4346
-
-
Herring, B.L.1
Tsui, R.2
Peddada, L.3
Busch, M.4
Delwart, E.L.5
-
94
-
-
84866144158
-
Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing
-
[CrossRef] [PubMed]
-
Li, H.; Stoddard, M.B.; Wang, S.; Blair, L.M.; Giorgi, E.E.; Parrish, E.H.; Learn, G.H.; Hraber, P.; Goepfert, P.A.; Saag, M.S.; Denny, T.N., et al. Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing. PLoS Pathog. 2012, 8, e1002880. [CrossRef] [PubMed]
-
(2012)
Plos Pathog
, vol.8
-
-
Li, H.1
Stoddard, M.B.2
Wang, S.3
Blair, L.M.4
Giorgi, E.E.5
Parrish, E.H.6
Learn, G.H.7
Hraber, P.8
Goepfert, P.A.9
Saag, M.S.10
Denny, T.N.11
-
95
-
-
84929497785
-
Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4
-
[CrossRef] [PubMed]
-
Stoddard, M.B.; Li, H.; Wang, S.; Saeed, M.; Andrus, L.; Ding, W.; Jiang, X.; Learn, G.H.; von Schaewen, M.; Wen, J., et al. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4. MBio 2015, 6, e02518-14. [CrossRef] [PubMed]
-
(2015)
Mbio
, vol.6
-
-
Stoddard, M.B.1
Li, H.2
Wang, S.3
Saeed, M.4
Andrus, L.5
Ding, W.6
Jiang, X.7
Learn, G.H.8
Von Schaewen, M.9
Wen, J.10
-
96
-
-
84929492696
-
Transmitted/founder hepatitis c viruses induce cell-type- and genotype-specific differences in innate signaling within the liver
-
[CrossRef] [PubMed]
-
Mitchell, A.M.; Stone, A.E.; Cheng, L.; Ballinger, K.; Edwards, M.G.; Stoddard, M.; Li, H.; Golden-Mason, L.; Shaw, G.M.; Khetani, S., et al. Transmitted/founder hepatitis c viruses induce cell-type- and genotype-specific differences in innate signaling within the liver. MBio 2015, 6, e02510-14. [CrossRef] [PubMed]
-
(2015)
Mbio
, vol.6
-
-
Mitchell, A.M.1
Stone, A.E.2
Cheng, L.3
Ballinger, K.4
Edwards, M.G.5
Stoddard, M.6
Li, H.7
Golden-Mason, L.8
Shaw, G.M.9
Khetani, S.10
-
97
-
-
15844406550
-
HyPhy: Hypothesis testing using phylogenies
-
[CrossRef] [PubMed]
-
Pond, S.L.; Frost, S.D.; Muse, S.V. HyPhy: Hypothesis testing using phylogenies. Bioinformatics 2005, 21, 676–679. [CrossRef] [PubMed]
-
(2005)
Bioinformatics
, vol.21
, pp. 676-679
-
-
Pond, S.L.1
Frost, S.D.2
Muse, S.V.3
-
98
-
-
84890330527
-
MEGA6: Molecular evolutionary genetics analysis version 6.0
-
[CrossRef] [PubMed]
-
Tamura, K.; Stecher, G.; Filipski, A.; Kumar, S. MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 2013, 30, 2725–2729. [CrossRef] [PubMed]
-
(2013)
Mol. Biol. Evol
, vol.30
, pp. 2725-2729
-
-
Tamura, K.1
Stecher, G.2
Filipski, A.3
Kumar, S.4
-
99
-
-
2542445427
-
ConSurf: Identification of functional regions in proteins by surface-mapping of phylogenetic information
-
[CrossRef] [PubMed]
-
Glaser, F.; Pupko, T.; Paz, I.; Bell, R.E.; Bechor-Shental, D.; Martz, E.; Ben-Tal, N. ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 2003, 19, 163–164. [CrossRef] [PubMed]
-
(2003)
Bioinformatics
, vol.19
, pp. 163-164
-
-
Glaser, F.1
Pupko, T.2
Paz, I.3
Bell, R.E.4
Bechor-Shental, D.5
Martz, E.6
Ben-Tal, N.7
-
100
-
-
84869143643
-
Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host
-
[CrossRef] [PubMed]
-
Brown, R.J.; Hudson, N.; Wilson, G.; Rehman, S.U.; Jabbari, S.; Hu, K.; Tarr, A.W.; Borrow, P.; Joyce, M.; Lewis, J., et al. Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host. J. Virol. 2012, 86, 11956–11966. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 11956-11966
-
-
Brown, R.J.1
Hudson, N.2
Wilson, G.3
Rehman, S.U.4
Jabbari, S.5
Hu, K.6
Tarr, A.W.7
Borrow, P.8
Joyce, M.9
Lewis, J.10
-
101
-
-
84888070513
-
Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host
-
[CrossRef] [PubMed]
-
D’Arienzo, V.; Moreau, A.; D’Alteroche, L.; Gissot, V.; Blanchard, E.; Gaudy-Graffin, C.; Roch, E.; Dubois, F.; Giraudeau, B.; Plantier, J.C., et al. Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host. J. Virol. 2013, 87, 13609–13618. [CrossRef] [PubMed]
-
(2013)
J. Virol
, vol.87
, pp. 13609-13618
-
-
D’Arienzo, V.1
Moreau, A.2
D’Alteroche, L.3
Gissot, V.4
Blanchard, E.5
Gaudy-Graffin, C.6
Roch, E.7
Dubois, F.8
Giraudeau, B.9
Plantier, J.C.10
-
102
-
-
84887497646
-
Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses
-
[CrossRef] [PubMed]
-
Honegger, J.R.; Kim, S.; Price, A.A.; Kohout, J.A.; McKnight, K.L.; Prasad, M.R.; Lemon, S.M.; Grakoui, A.; Walker, C.M. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat. Med. 2013, 19, 1529–1533. [CrossRef] [PubMed]
-
(2013)
Nat. Med
, vol.19
, pp. 1529-1533
-
-
Honegger, J.R.1
Kim, S.2
Price, A.A.3
Kohout, J.A.4
McKnight, K.L.5
Prasad, M.R.6
Lemon, S.M.7
Grakoui, A.8
Walker, C.M.9
-
103
-
-
84865085855
-
Unexpected maintenance of hepatitis C viral diversity following liver transplantation
-
[CrossRef] [PubMed]
-
Gray, R.R.; Strickland, S.L.; Veras, N.M.; Goodenow, M.M.; Pybus, O.G.; Lemon, S.M.; Fried, M.W.; Nelson, D.R.; Salemi, M. Unexpected maintenance of hepatitis C viral diversity following liver transplantation. J. Virol. 2012, 86, 8432–8439. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 8432-8439
-
-
Gray, R.R.1
Strickland, S.L.2
Veras, N.M.3
Goodenow, M.M.4
Pybus, O.G.5
Lemon, S.M.6
Fried, M.W.7
Nelson, D.R.8
Salemi, M.9
-
104
-
-
77956147218
-
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
-
[CrossRef] [PubMed]
-
Fafi-Kremer, S.; Fofana, I.; Soulier, E.; Carolla, P.; Meuleman, P.; Leroux-Roels, G.; Patel, A.H.; Cosset, F.L.; Pessaux, P.; Doffoel, M., et al. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J. Exp. Med. 2010, 207, 2019–2031. [CrossRef] [PubMed]
-
(2010)
J. Exp. Med
, vol.207
, pp. 2019-2031
-
-
Fafi-Kremer, S.1
Fofana, I.2
Soulier, E.3
Carolla, P.4
Meuleman, P.5
Leroux-Roels, G.6
Patel, A.H.7
Cosset, F.L.8
Pessaux, P.9
Doffoel, M.10
-
105
-
-
84866177809
-
Quantifying the diversification of hepatitis C virus (HCV) during primary infection: Estimates of the in vivo mutation rate
-
[CrossRef] [PubMed]
-
Ribeiro, R.M.; Li, H.; Wang, S.; Stoddard, M.B.; Learn, G.H.; Korber, B.T.; Bhattacharya, T.; Guedj, J.; Parrish, E.H.; Hahn, B.H., et al. Quantifying the diversification of hepatitis C virus (HCV) during primary infection: Estimates of the in vivo mutation rate. PLoS Pathog. 2012, 8, e1002881. [CrossRef] [PubMed]
-
(2012)
Plos Pathog
, vol.8
-
-
Ribeiro, R.M.1
Li, H.2
Wang, S.3
Stoddard, M.B.4
Learn, G.H.5
Korber, B.T.6
Bhattacharya, T.7
Guedj, J.8
Parrish, E.H.9
Hahn, B.H.10
-
106
-
-
78650407546
-
Dynamic coinfection with multiple viral subtypes in acute hepatitis C
-
[CrossRef] [PubMed]
-
Smith, J.A.; Aberle, J.H.; Fleming, V.M.; Ferenci, P.; Thomson, E.C.; Karayiannis, P.; McLean, A.R.; Holzmann, H.; Klenerman, P. Dynamic coinfection with multiple viral subtypes in acute hepatitis C. J. Infect. Dis. 2010, 202, 1770–1779. [CrossRef] [PubMed]
-
(2010)
J. Infect. Dis
, vol.202
, pp. 1770-1779
-
-
Smith, J.A.1
Aberle, J.H.2
Fleming, V.M.3
Ferenci, P.4
Thomson, E.C.5
Karayiannis, P.6
McLean, A.R.7
Holzmann, H.8
Klenerman, P.9
-
107
-
-
84890277181
-
Use of short tandem repeat fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies
-
[CrossRef] [PubMed]
-
Edwards, V.C.; McClure, C.P.; Brown, R.J.; Thompson, E.; Irving, W.L.; Ball, J.K. Use of short tandem repeat fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies. J. Gen. Virol. 2014, 95, 66–70. [CrossRef] [PubMed]
-
(2014)
J. Gen. Virol
, vol.95
, pp. 66-70
-
-
Edwards, V.C.1
McClure, C.P.2
Brown, R.J.3
Thompson, E.4
Irving, W.L.5
Ball, J.K.6
-
108
-
-
78650339143
-
Virus infection: A dynamic-and challenging-concept
-
[CrossRef] [PubMed]
-
Irving, W.L.; Brown, R.J. Acute hepatitis C virus infection: A dynamic-and challenging-concept. J. Infect. Dis. 2010, 202, 1765–1767. [CrossRef] [PubMed]
-
(2010)
J. Infect. Dis
, vol.202
, pp. 1765-1767
-
-
Irving, W.L.1
Brown, R.J.2
Acute Hepatitis, C.3
-
109
-
-
0034646996
-
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
-
[CrossRef] [PubMed]
-
Farci, P.; Shimoda, A.; Coiana, A.; Diaz, G.; Peddis, G.; Melpolder, J.C.; Strazzera, A.; Chien, D.Y.; Munoz, S.J.; Balestrieri, A., et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000, 288, 339–344. [CrossRef] [PubMed]
-
(2000)
Science
, vol.288
, pp. 339-344
-
-
Farci, P.1
Shimoda, A.2
Coiana, A.3
Diaz, G.4
Peddis, G.5
Melpolder, J.C.6
Strazzera, A.7
Chien, D.Y.8
Munoz, S.J.9
Balestrieri, A.10
-
110
-
-
0032976214
-
Virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy
-
[PubMed]
-
Ray, S.C.; Wang, Y.M.; Laeyendecker, O.; Ticehurst, J.R.; Villano, S.A.; Thomas, D.L. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy. J. Virol. 1999, 73, 2938–2946. [PubMed]
-
(1999)
J. Virol
, vol.73
, pp. 2938-2946
-
-
Ray, S.C.1
Wang, Y.M.2
Laeyendecker, O.3
Ticehurst, J.R.4
Villano, S.A.5
Thomas, D.L.6
Acute Hepatitis, C.7
-
111
-
-
1842510015
-
High-resolution phylogenetic analysis of hepatitis c virus adaptation and its relationship to disease progression
-
[CrossRef] [PubMed]
-
Sheridan, I.; Pybus, O.G.; Holmes, E.C.; Klenerman, P. High-resolution phylogenetic analysis of hepatitis c virus adaptation and its relationship to disease progression. J. Virol. 2004, 78, 3447–3454. [CrossRef] [PubMed]
-
(2004)
J. Virol
, vol.78
, pp. 3447-3454
-
-
Sheridan, I.1
Pybus, O.G.2
Holmes, E.C.3
Klenerman, P.4
-
112
-
-
80053439798
-
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Bull, R.A.; Luciani, F.; McElroy, K.; Gaudieri, S.; Pham, S.T.; Chopra, A.; Cameron, B.; Maher, L.; Dore, G.J.; White, P.A., et al. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog. 2011, 7, e1002243. [CrossRef] [PubMed]
-
(2011)
Plos Pathog
, vol.7
-
-
Bull, R.A.1
Luciani, F.2
McElroy, K.3
Gaudieri, S.4
Pham, S.T.5
Chopra, A.6
Cameron, B.7
Maher, L.8
Dore, G.J.9
White, P.A.10
-
113
-
-
80655142505
-
Transmission of clonal hepatitis C virus genomes reveals thedominant but transitory role of CD8(+) T cells in early viral evolution
-
[CrossRef] [PubMed]
-
Callendret, B.; Bukh, J.; Eccleston, H.B.; Heksch, R.; Hasselschwert, D.L.; Purcell, R.H.; Hughes, A.L.; Walker, C.M. Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8(+) T cells in early viral evolution. J. Virol. 2011, 85, 11833–11845. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 11833-11845
-
-
Callendret, B.1
Bukh, J.2
Eccleston, H.B.3
Heksch, R.4
Hasselschwert, D.L.5
Purcell, R.H.6
Hughes, A.L.7
Walker, C.M.8
-
114
-
-
35448965263
-
Viral sequence evolution in acute hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Kuntzen, T.; Timm, J.; Berical, A.; Lewis-Ximenez, L.L.; Jones, A.; Nolan, B.; Schulze zur Wiesch, J.; Li, B.; Schneidewind, A.; Kim, A.Y., et al. Viral sequence evolution in acute hepatitis C virus infection. J. Virol. 2007, 81, 11658–11668. [CrossRef] [PubMed]
-
(2007)
J. Virol
, vol.81
, pp. 11658-11668
-
-
Kuntzen, T.1
Timm, J.2
Berical, A.3
Lewis-Ximenez, L.L.4
Jones, A.5
Nolan, B.6
Schulze Zur Wiesch, J.7
Li, B.8
Schneidewind, A.9
Kim, A.Y.10
-
115
-
-
84928542116
-
The transmitted/founder viruses rapidly escape from CD8+ T cell responses in acute hepatitis C infection
-
[CrossRef] [PubMed]
-
Bull, R.A.; Leung, P.; Gaudieri, S.; Deshpande, P.; Cameron, B.; Walker, M.; Chopra, A.; Lloyd, A.R.; Luciani, F. The transmitted/founder viruses rapidly escape from CD8+ T cell responses in acute hepatitis C infection. J. Virol. 2015, 89, 5478–5490. [CrossRef] [PubMed]
-
(2015)
J. Virol
, vol.89
, pp. 5478-5490
-
-
Bull, R.A.1
Leung, P.2
Gaudieri, S.3
Deshpande, P.4
Cameron, B.5
Walker, M.6
Chopra, A.7
Lloyd, A.R.8
Luciani, F.9
-
116
-
-
66149119738
-
Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus
-
[CrossRef] [PubMed]
-
Dowd, K.A.; Netski, D.M.; Wang, X.H.; Cox, A.L.; Ray, S.C. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology 2009, 136, 2377–2386. [CrossRef] [PubMed]
-
(2009)
Gastroenterology
, vol.136
, pp. 2377-2386
-
-
Dowd, K.A.1
Netski, D.M.2
Wang, X.H.3
Cox, A.L.4
Ray, S.C.5
-
117
-
-
84896974296
-
Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses
-
[CrossRef] [PubMed]
-
Osburn, W.O.; Snider, A.E.; Wells, B.L.; Latanich, R.; Bailey, J.R.; Thomas, D.L.; Cox, A.L.; Ray, S.C. Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses. Hepatology 2014, 59, 2140–2151. [CrossRef] [PubMed]
-
(2014)
Hepatology
, vol.59
, pp. 2140-2151
-
-
Osburn, W.O.1
Snider, A.E.2
Wells, B.L.3
Latanich, R.4
Bailey, J.R.5
Thomas, D.L.6
Cox, A.L.7
Ray, S.C.8
-
118
-
-
34347230939
-
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
-
[CrossRef] [PubMed]
-
Pestka, J.M.; Zeisel, M.B.; Blaser, E.; Schurmann, P.; Bartosch, B.; Cosset, F.L.; Patel, A.H.; Meisel, H.; Baumert, J.; Viazov, S., et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc. Natl. Acad. Sci. USA 2007, 104, 6025–6030. [CrossRef] [PubMed]
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 6025-6030
-
-
Pestka, J.M.1
Zeisel, M.B.2
Blaser, E.3
Schurmann, P.4
Bartosch, B.5
Cosset, F.L.6
Patel, A.H.7
Meisel, H.8
Baumert, J.9
Viazov, S.10
-
119
-
-
84912074146
-
Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes
-
[CrossRef] [PubMed]
-
Graw, F.; Balagopal, A.; Kandathil, A.J.; Ray, S.C.; Thomas, D.L.; Ribeiro, R.M.; Perelson, A.S. Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes. PLoS Comput. Biol. 2014, 10, e1003934. [CrossRef] [PubMed]
-
(2014)
Plos Comput. Biol
, vol.10
-
-
Graw, F.1
Balagopal, A.2
Kandathil, A.J.3
Ray, S.C.4
Thomas, D.L.5
Ribeiro, R.M.6
Perelson, A.S.7
-
120
-
-
84865955571
-
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis
-
[CrossRef] [PubMed]
-
Farci, P.; Wollenberg, K.; Diaz, G.; Engle, R.E.; Lai, M.E.; Klenerman, P.; Purcell, R.H.; Pybus, O.G.; Alter, H.J. Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis. Proc. Natl. Acad. Sci. USA 2012, 109, 14562–14567. [CrossRef] [PubMed]
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 14562-14567
-
-
Farci, P.1
Wollenberg, K.2
Diaz, G.3
Engle, R.E.4
Lai, M.E.5
Klenerman, P.6
Purcell, R.H.7
Pybus, O.G.8
Alter, H.J.9
-
121
-
-
33744812765
-
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively
-
[CrossRef] [PubMed]
-
Farci, P.; Quinti, I.; Farci, S.; Alter, H.J.; Strazzera, R.; Palomba, E.; Coiana, A.; Cao, D.; Casadei, A.M.; Ledda, R., et al. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc. Natl. Acad. Sci. USA 2006, 103, 8475–8480. [CrossRef] [PubMed]
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 8475-8480
-
-
Farci, P.1
Quinti, I.2
Farci, S.3
Alter, H.J.4
Strazzera, R.5
Palomba, E.6
Coiana, A.7
Cao, D.8
Casadei, A.M.9
Ledda, R.10
-
122
-
-
43249089764
-
Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C
-
[CrossRef] [PubMed]
-
Li, H.; McMahon, B.J.; McArdle, S.; Bruden, D.; Sullivan, D.G.; Shelton, D.; Deubner, H.; Gretch, D.R. Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C. Virology 2008, 375, 580–591. [CrossRef] [PubMed]
-
(2008)
Virology
, vol.375
, pp. 580-591
-
-
Li, H.1
McMahon, B.J.2
McArdle, S.3
Bruden, D.4
Sullivan, D.G.5
Shelton, D.6
Deubner, H.7
Gretch, D.R.8
-
123
-
-
21444451974
-
Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection
-
[CrossRef] [PubMed]
-
Brown, R.J.; Juttla, V.S.; Tarr, A.W.; Finnis, R.; Irving, W.L.; Hemsley, S.; Flower, D.R.; Borrow, P.; Ball, J.K. Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection. J. Gen. Virol. 2005, 86, 1931–1942. [CrossRef] [PubMed]
-
(2005)
J. Gen. Virol
, vol.86
, pp. 1931-1942
-
-
Brown, R.J.1
Juttla, V.S.2
Tarr, A.W.3
Finnis, R.4
Irving, W.L.5
Hemsley, S.6
Flower, D.R.7
Borrow, P.8
Ball, J.K.9
-
124
-
-
84911366383
-
Analysis of the evolution and structure of a complex intrahost viral population in chronic hepatitis C virus mapped by ultradeep pyrosequencing
-
[CrossRef] [PubMed]
-
Palmer, B.A.; Dimitrova, Z.; Skums, P.; Crosbie, O.; Kenny-Walsh, E.; Fanning, L.J. Analysis of the evolution and structure of a complex intrahost viral population in chronic hepatitis C virus mapped by ultradeep pyrosequencing. J. Virol. 2014, 88, 13709–13721. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 13709-13721
-
-
Palmer, B.A.1
Dimitrova, Z.2
Skums, P.3
Crosbie, O.4
Kenny-Walsh, E.5
Fanning, L.J.6
-
125
-
-
79960848222
-
Temporal variations in the hepatitis C virus intrahost population during chronic infection
-
[CrossRef] [PubMed]
-
Ramachandran, S.; Campo, D.S.; Dimitrova, Z.E.; Xia, G.L.; Purdy, M.A.; Khudyakov, Y.E. Temporal variations in the hepatitis C virus intrahost population during chronic infection. J. Virol. 2011, 85, 6369–6380. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 6369-6380
-
-
Ramachandran, S.1
Campo, D.S.2
Dimitrova, Z.E.3
Xia, G.L.4
Purdy, M.A.5
Khudyakov, Y.E.6
-
126
-
-
84869210366
-
Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure
-
[CrossRef] [PubMed]
-
Bailey, J.R.; Laskey, S.; Wasilewski, L.N.; Munshaw, S.; Fanning, L.J.; Kenny-Walsh, E.; Ray, S.C. Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure. J. Virol. 2012, 86, 12582–12590. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 12582-12590
-
-
Bailey, J.R.1
Laskey, S.2
Wasilewski, L.N.3
Munshaw, S.4
Fanning, L.J.5
Kenny-Walsh, E.6
Ray, S.C.7
-
127
-
-
3042841149
-
Neutralizing antibody response during acute and chronic hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Logvinoff, C.; Major, M.E.; Oldach, D.; Heyward, S.; Talal, A.; Balfe, P.; Feinstone, S.M.; Alter, H.; Rice, C.M.; McKeating, J.A. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 2004, 101, 10149–10154. [CrossRef] [PubMed]
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 10149-10154
-
-
Logvinoff, C.1
Major, M.E.2
Oldach, D.3
Heyward, S.4
Talal, A.5
Balfe, P.6
Feinstone, S.M.7
Alter, H.8
Rice, C.M.9
McKeating, J.A.10
-
128
-
-
33847015308
-
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo
-
[CrossRef] [PubMed]
-
Von Hahn, T.; Yoon, J.C.; Alter, H.; Rice, C.M.; Rehermann, B.; Balfe, P.; McKeating, J.A. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007, 132, 667–678. [CrossRef] [PubMed]
-
(2007)
Gastroenterology
, vol.132
, pp. 667-678
-
-
Von Hahn, T.1
Yoon, J.C.2
Alter, H.3
Rice, C.M.4
Rehermann, B.5
Balfe, P.6
McKeating, J.A.7
-
129
-
-
84905851930
-
Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region
-
[CrossRef] [PubMed]
-
Irving, W.L.; Rupp, D.; McClure, C.P.; Than, L.M.; Titman, A.; Ball, J.K.; Steinmann, E.; Bartenschlager, R.; Pietschmann, T.; Brown, R.J. Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region. Antivir. Res. 2014, 110, 52–59. [CrossRef] [PubMed]
-
(2014)
Antivir. Res
, vol.110
, pp. 52-59
-
-
Irving, W.L.1
Rupp, D.2
McClure, C.P.3
Than, L.M.4
Titman, A.5
Ball, J.K.6
Steinmann, E.7
Bartenschlager, R.8
Pietschmann, T.9
Brown, R.J.10
-
130
-
-
4444261389
-
Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity
-
[CrossRef] [PubMed]
-
Fernandez, J.; Taylor, D.; Morhardt, D.R.; Mihalik, K.; Puig, M.; Rice, C.M.; Feinstone, S.M.; Major, M.E. Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity. J. Virol. 2004, 78, 9782–9789. [CrossRef] [PubMed]
-
(2004)
J. Virol
, vol.78
, pp. 9782-9789
-
-
Fernandez, J.1
Taylor, D.2
Morhardt, D.R.3
Mihalik, K.4
Puig, M.5
Rice, C.M.6
Feinstone, S.M.7
Major, M.E.8
-
131
-
-
37849010852
-
Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus
-
[CrossRef] [PubMed]
-
Meunier, J.C.; Russell, R.S.; Goossens, V.; Priem, S.; Walter, H.; Depla, E.; Union, A.; Faulk, K.N.; Bukh, J.; Emerson, S.U., et al. Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus. J. Virol. 2008, 82, 966–973. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 966-973
-
-
Meunier, J.C.1
Russell, R.S.2
Goossens, V.3
Priem, S.4
Walter, H.5
Depla, E.6
Union, A.7
Faulk, K.N.8
Bukh, J.9
Emerson, S.U.10
-
132
-
-
2942643931
-
Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity
-
[CrossRef] [PubMed]
-
Keck, Z.Y.; Sung, V.M.; Perkins, S.; Rowe, J.; Paul, S.; Liang, T.J.; Lai, M.M.; Foung, S.K. Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity. J. Virol. 2004, 78, 7257–7263. [CrossRef] [PubMed]
-
(2004)
J. Virol
, vol.78
, pp. 7257-7263
-
-
Keck, Z.Y.1
Sung, V.M.2
Perkins, S.3
Rowe, J.4
Paul, S.5
Liang, T.J.6
Lai, M.M.7
Foung, S.K.8
-
133
-
-
3843137346
-
Candidate vaccine based on the hepatitis C E1 protein: Tolerability and immunogenicity in healthy volunteers
-
[CrossRef] [PubMed]
-
Leroux-Roels, G.; Depla, E.; Hulstaert, F.; Tobback, L.; Dincq, S.; Desmet, J.; Desombere, I.; Maertens, G. A candidate vaccine based on the hepatitis C E1 protein: Tolerability and immunogenicity in healthy volunteers. Vaccine 2004, 22, 3080–3086. [CrossRef] [PubMed]
-
(2004)
Vaccine
, vol.22
, pp. 3080-3086
-
-
Leroux-Roels, G.1
Depla, E.2
Hulstaert, F.3
Tobback, L.4
Dincq, S.5
Desmet, J.6
Desombere, I.7
Maertens, G.A.8
-
134
-
-
84879477644
-
Determination of the human antibody response to the neutralization epitopes encompassing amino acids 313–327 and 432–443 of hepatitis C virus E1E2 glycoproteins
-
[CrossRef] [PubMed]
-
Liu, R.; Rao, H.; Wang, J.; Xie, X.; Jiang, D.; Pan, X.; Zhao, P.; Zhang, H.; Wei, L. Determination of the human antibody response to the neutralization epitopes encompassing amino acids 313–327 and 432–443 of hepatitis C virus E1E2 glycoproteins. PLoS ONE 2013, 8, e66872. [CrossRef] [PubMed]
-
(2013)
Plos ONE
, vol.8
-
-
Liu, R.1
Rao, H.2
Wang, J.3
Xie, X.4
Jiang, D.5
Pan, X.6
Zhao, P.7
Zhang, H.8
Wei, L.9
-
135
-
-
12644289313
-
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
-
[CrossRef] [PubMed]
-
Farci, P.; Shimoda, A.; Wong, D.; Cabezon, T.; De Gioannis, D.; Strazzera, A.; Shimizu, Y.; Shapiro, M.; Alter, H.J.; Purcell, R.H. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA 1996, 93, 15394–15399. [CrossRef] [PubMed]
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 15394-15399
-
-
Farci, P.1
Shimoda, A.2
Wong, D.3
Cabezon, T.4
De Gioannis, D.5
Strazzera, A.6
Shimizu, Y.7
Shapiro, M.8
Alter, H.J.9
Purcell, R.H.10
-
136
-
-
0034774844
-
Hypervariable region 1 of hepatitis C virus
-
[CrossRef]
-
Mondelli, M.U.; Cerino, A.; Segagni, L.; Meola, A.; Cividini, A.; Silini, E.; Nicosia, A. Hypervariable region 1 of hepatitis C virus: Immunological decoy or biologically relevant domain? Antivir. Res. 2001, 52, 153–159. [CrossRef]
-
(2001)
Immunological Decoy Or Biologically Relevant Domain? Antivir. Res
, vol.52
, pp. 153-159
-
-
Mondelli, M.U.1
Cerino, A.2
Segagni, L.3
Meola, A.4
Cividini, A.5
Silini, E.6
Nicosia, A.7
-
137
-
-
79951803564
-
Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein
-
[CrossRef] [PubMed]
-
Vieyres, G.; Dubuisson, J.; Patel, A.H. Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein. J. Gen. Virol. 2011, 92, 494–506. [CrossRef] [PubMed]
-
(2011)
J. Gen. Virol
, vol.92
, pp. 494-506
-
-
Vieyres, G.1
Dubuisson, J.2
Patel, A.H.3
-
138
-
-
79960485199
-
Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step
-
[CrossRef] [PubMed]
-
Sabo, M.C.; Luca, V.C.; Prentoe, J.; Hopcraft, S.E.; Blight, K.J.; Yi, M.; Lemon, S.M.; Ball, J.K.; Bukh, J.; Evans, M.J. Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step. J. Virol. 2011, 85, 7005–7019. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 7005-7019
-
-
Sabo, M.C.1
Luca, V.C.2
Prentoe, J.3
Hopcraft, S.E.4
Blight, K.J.5
Yi, M.6
Lemon, S.M.7
Ball, J.K.8
Bukh, J.9
Evans, M.J.10
-
139
-
-
0033761870
-
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes
-
[CrossRef] [PubMed]
-
Hadlock, K.G.; Lanford, R.E.; Perkins, S.; Rowe, J.; Yang, Q.; Levy, S.; Pileri, P.; Abrignani, S.; Foung, S.K. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J. Virol. 2000, 74, 10407–10416. [CrossRef] [PubMed]
-
(2000)
J. Virol
, vol.74
, pp. 10407-10416
-
-
Hadlock, K.G.1
Lanford, R.E.2
Perkins, S.3
Rowe, J.4
Yang, Q.5
Levy, S.6
Pileri, P.7
Abrignani, S.8
Foung, S.K.9
-
140
-
-
44949231397
-
Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies
-
[CrossRef] [PubMed]
-
Keck, Z.Y.; Li, T.K.; Xia, J.; Gal-Tanamy, M.; Olson, O.; Li, S.H.; Patel, A.H.; Ball, J.K.; Lemon, S.M.; Foung, S.K. Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies. J. Virol. 2008, 82, 6061–6066. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 6061-6066
-
-
Keck, Z.Y.1
Li, T.K.2
Xia, J.3
Gal-Tanamy, M.4
Olson, O.5
Li, S.H.6
Patel, A.H.7
Ball, J.K.8
Lemon, S.M.9
Foung, S.K.10
-
141
-
-
33846064716
-
Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions
-
[CrossRef] [PubMed]
-
Keck, Z.Y.; Xia, J.; Cai, Z.; Li, T.K.; Owsianka, A.M.; Patel, A.H.; Luo, G.; Foung, S.K. Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions. J. Virol. 2007, 81, 1043–1047. [CrossRef] [PubMed]
-
(2007)
J. Virol
, vol.81
, pp. 1043-1047
-
-
Keck, Z.Y.1
Xia, J.2
Cai, Z.3
Li, T.K.4
Owsianka, A.M.5
Patel, A.H.6
Luo, G.7
Foung, S.K.8
-
142
-
-
84861205239
-
Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate
-
[CrossRef] [PubMed]
-
Keck, Z.Y.; Xia, J.; Wang, Y.; Wang, W.; Krey, T.; Prentoe, J.; Carlsen, T.; Li, A.Y.; Patel, A.H.; Lemon, S.M., et al. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate. PLoS Pathog. 2012, 8, e1002653. [CrossRef] [PubMed]
-
(2012)
Plos Pathog
, vol.8
-
-
Keck, Z.Y.1
Xia, J.2
Wang, Y.3
Wang, W.4
Krey, T.5
Prentoe, J.6
Carlsen, T.7
Li, A.Y.8
Patel, A.H.9
Lemon, S.M.10
-
143
-
-
80054977124
-
Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations
-
[CrossRef] [PubMed]
-
Keck, Z.Y.; Saha, A.; Xia, J.; Wang, Y.; Lau, P.; Krey, T.; Rey, F.A.; Foung, S.K. Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations. J. Virol. 2011, 85, 10451–10463. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 10451-10463
-
-
Keck, Z.Y.1
Saha, A.2
Xia, J.3
Wang, Y.4
Lau, P.5
Krey, T.6
Rey, F.A.7
Foung, S.K.8
-
144
-
-
0032530620
-
Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties
-
[CrossRef] [PubMed]
-
Habersetzer, F.; Fournillier, A.; Dubuisson, J.; Rosa, D.; Abrignani, S.; Wychowski, C.; Nakano, I.; Trepo, C.; Desgranges, C.; Inchauspe, G. Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology 1998, 249, 32–41. [CrossRef] [PubMed]
-
(1998)
Virology
, vol.249
, pp. 32-41
-
-
Habersetzer, F.1
Fournillier, A.2
Dubuisson, J.3
Rosa, D.4
Abrignani, S.5
Wychowski, C.6
Nakano, I.7
Trepo, C.8
Desgranges, C.9
Inchauspe, G.10
-
145
-
-
38049083122
-
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat
-
[CrossRef] [PubMed]
-
Law, M.; Maruyama, T.; Lewis, J.; Giang, E.; Tarr, A.W.; Stamataki, Z.; Gastaminza, P.; Chisari, F.V.; Jones, I.M.; Fox, R.I., et al. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat. Med. 2008, 14, 25–27. [CrossRef] [PubMed]
-
(2008)
Med
, vol.14
, pp. 25-27
-
-
Law, M.1
Maruyama, T.2
Lewis, J.3
Giang, E.4
Tarr, A.W.5
Stamataki, Z.6
Gastaminza, P.7
Chisari, F.V.8
Jones, I.M.9
Fox, R.I.10
-
146
-
-
36048952785
-
Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus
-
[CrossRef] [PubMed]
-
Johansson, D.X.; Voisset, C.; Tarr, A.W.; Aung, M.; Ball, J.K.; Dubuisson, J.; Persson, M.A. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc. Natl. Acad. Sci. USA 2007, 104, 16269–16274. [CrossRef] [PubMed]
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 16269-16274
-
-
Johansson, D.X.1
Voisset, C.2
Tarr, A.W.3
Aung, M.4
Ball, J.K.5
Dubuisson, J.6
Persson, M.A.7
-
147
-
-
37849016609
-
Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein
-
[CrossRef] [PubMed]
-
Perotti, M.; Mancini, N.; Diotti, R.A.; Tarr, A.W.; Ball, J.K.; Owsianka, A.; Adair, R.; Patel, A.H.; Clementi, M.; Burioni, R. Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein. J. Virol. 2008, 82, 1047–1052. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 1047-1052
-
-
Perotti, M.1
Mancini, N.2
Diotti, R.A.3
Tarr, A.W.4
Ball, J.K.5
Owsianka, A.6
Adair, R.7
Patel, A.H.8
Clementi, M.9
Burioni, R.10
-
148
-
-
4544331326
-
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Burioni, R.; Mancini, N.; Carletti, S.; Perotti, M.; Grieco, A.; Canducci, F.; Varaldo, P.E.; Clementi, M. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection. Virology 2004, 327, 242–248. [CrossRef] [PubMed]
-
(2004)
Virology
, vol.327
, pp. 242-248
-
-
Burioni, R.1
Mancini, N.2
Carletti, S.3
Perotti, M.4
Grieco, A.5
Canducci, F.6
Varaldo, P.E.7
Clementi, M.8
-
149
-
-
0034807355
-
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries
-
[CrossRef] [PubMed]
-
Bugli, F.; Mancini, N.; Kang, C.Y.; Di Campli, C.; Grieco, A.; Manzin, A.; Gabrielli, A.; Gasbarrini, A.; Fadda, G.; Varaldo, P.E., et al. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J. Virol. 2001, 75, 9986–9990. [CrossRef] [PubMed]
-
(2001)
J. Virol
, vol.75
, pp. 9986-9990
-
-
Bugli, F.1
Mancini, N.2
Kang, C.Y.3
Di Campli, C.4
Grieco, A.5
Manzin, A.6
Gabrielli, A.7
Gasbarrini, A.8
Fadda, G.9
Varaldo, P.E.10
-
150
-
-
84859965965
-
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
-
[CrossRef] [PubMed]
-
Giang, E.; Dorner, M.; Prentoe, J.C.; Dreux, M.; Evans, M.J.; Bukh, J.; Rice, C.M.; Ploss, A.; Burton, D.R.; Law, M. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc. Natl. Acad. Sci. USA 2012, 109, 6205–6210. [CrossRef] [PubMed]
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 6205-6210
-
-
Giang, E.1
Dorner, M.2
Prentoe, J.C.3
Dreux, M.4
Evans, M.J.5
Bukh, J.6
Rice, C.M.7
Ploss, A.8
Burton, D.R.9
Law, M.10
-
151
-
-
84896977436
-
The past, present and future of neutralizing antibodies for hepatitis C virus
-
[CrossRef] [PubMed]
-
Ball, J.K.; Tarr, A.W.; McKeating, J.A. The past, present and future of neutralizing antibodies for hepatitis C virus. Antivir. Res. 2014, 105, 100–111. [CrossRef] [PubMed]
-
(2014)
Antivir. Res
, vol.105
, pp. 100-111
-
-
Ball, J.K.1
Tarr, A.W.2
McKeating, J.A.3
-
152
-
-
83755183801
-
The role of neutralizing antibodies in hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Edwards, V.C.; Tarr, A.W.; Urbanowicz, R.A.; Ball, J.K. The role of neutralizing antibodies in hepatitis C virus infection. J. Gen. Virol. 2012, 93, 1–19. [CrossRef] [PubMed]
-
(2012)
J. Gen. Virol
, vol.93
, pp. 1-19
-
-
Edwards, V.C.1
Tarr, A.W.2
Urbanowicz, R.A.3
Ball, J.K.4
-
153
-
-
0032923618
-
Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees
-
[PubMed]
-
Bassett, S.E.; Thomas, D.L.; Brasky, K.M.; Lanford, R.E. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J. Virol. 1999, 73, 1118–1126. [PubMed]
-
(1999)
J. Virol
, vol.73
, pp. 1118-1126
-
-
Bassett, S.E.1
Thomas, D.L.2
Brasky, K.M.3
Lanford, R.E.4
-
154
-
-
72249087933
-
Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection
-
[CrossRef] [PubMed]
-
Osburn, W.O.; Fisher, B.E.; Dowd, K.A.; Urban, G.; Liu, L.; Ray, S.C.; Thomas, D.L.; Cox, A.L. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 2010, 138, 315–324. [CrossRef] [PubMed]
-
(2010)
Gastroenterology
, vol.138
, pp. 315-324
-
-
Osburn, W.O.1
Fisher, B.E.2
Dowd, K.A.3
Urban, G.4
Liu, L.5
Ray, S.C.6
Thomas, D.L.7
Cox, A.L.8
-
155
-
-
20944449916
-
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Lavillette, D.; Morice, Y.; Germanidis, G.; Donot, P.; Soulier, A.; Pagkalos, E.; Sakellariou, G.; Intrator, L.; Bartosch, B.; Pawlotsky, J.M., et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J. Virol. 2005, 79, 6023–6034. [CrossRef] [PubMed]
-
(2005)
J. Virol
, vol.79
, pp. 6023-6034
-
-
Lavillette, D.1
Morice, Y.2
Germanidis, G.3
Donot, P.4
Soulier, A.5
Pagkalos, E.6
Sakellariou, G.7
Intrator, L.8
Bartosch, B.9
Pawlotsky, J.M.10
-
156
-
-
79955384226
-
Patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: Genetic subtype defines antigenic but not neutralization serotype
-
[CrossRef] [PubMed]
-
Tarr, A.W.; Urbanowicz, R.A.; Hamed, M.R.; Albecka, A.; McClure, C.P.; Brown, R.J.; Irving, W.L.; Dubuisson, J.; Ball, J.K. Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: Genetic subtype defines antigenic but not neutralization serotype. J. Virol. 2011, 85, 4246–4257. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 4246-4257
-
-
Tarr, A.W.1
Urbanowicz, R.A.2
Hamed, M.R.3
Albecka, A.4
McClure, C.P.5
Brown, R.J.6
Irving, W.L.7
Dubuisson, J.8
Ball, J.K.9
Hepatitis, C.10
-
157
-
-
20144383712
-
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1
-
[CrossRef] [PubMed]
-
Meunier, J.C.; Engle, R.E.; Faulk, K.; Zhao, M.; Bartosch, B.; Alter, H.; Emerson, S.U.; Cosset, F.L.; Purcell, R.H.; Bukh, J. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl. Acad. Sci. USA 2005, 102, 4560–4565. [CrossRef] [PubMed]
-
(2005)
Proc. Natl. Acad. Sci. USA
, vol.102
, pp. 4560-4565
-
-
Meunier, J.C.1
Engle, R.E.2
Faulk, K.3
Zhao, M.4
Bartosch, B.5
Alter, H.6
Emerson, S.U.7
Cosset, F.L.8
Purcell, R.H.9
Bukh, J.10
-
158
-
-
0036314509
-
Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles
-
[CrossRef] [PubMed]
-
Clayton, R.F.; Owsianka, A.; Aitken, J.; Graham, S.; Bhella, D.; Patel, A.H. Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles. J. Virol. 2002, 76, 7672–7682. [CrossRef] [PubMed]
-
(2002)
J. Virol
, vol.76
, pp. 7672-7682
-
-
Clayton, R.F.1
Owsianka, A.2
Aitken, J.3
Graham, S.4
Bhella, D.5
Patel, A.H.6
-
159
-
-
0032768960
-
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
-
[PubMed]
-
Flint, M.; Maidens, C.; Loomis-Price, L.D.; Shotton, C.; Dubuisson, J.; Monk, P.; Higginbottom, A.; Levy, S.; McKeating, J.A. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 1999, 73, 6235–6244. [PubMed]
-
(1999)
J. Virol
, vol.73
, pp. 6235-6244
-
-
Flint, M.1
Maidens, C.2
Loomis-Price, L.D.3
Shotton, C.4
Dubuisson, J.5
Monk, P.6
Higginbottom, A.7
Levy, S.8
McKeating, J.A.9
-
160
-
-
23844553059
-
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein
-
[CrossRef] [PubMed]
-
Owsianka, A.; Tarr, A.W.; Juttla, V.S.; Lavillette, D.; Bartosch, B.; Cosset, F.L.; Ball, J.K.; Patel, A.H. Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J. Virol. 2005, 79, 11095–11104. [CrossRef] [PubMed]
-
(2005)
J. Virol
, vol.79
, pp. 11095-11104
-
-
Owsianka, A.1
Tarr, A.W.2
Juttla, V.S.3
Lavillette, D.4
Bartosch, B.5
Cosset, F.L.6
Ball, J.K.7
Patel, A.H.8
-
161
-
-
58049196768
-
In vitro selection of a neutralization-resistant hepatitis C virus escape mutant
-
[CrossRef] [PubMed]
-
Gal-Tanamy, M.; Keck, Z.Y.; Yi, M.; McKeating, J.A.; Patel, A.H.; Foung, S.K.; Lemon, S.M. In vitro selection of a neutralization-resistant hepatitis C virus escape mutant. Proc. Natl. Acad. Sci. USA 2008, 105, 19450–19455. [CrossRef] [PubMed]
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 19450-19455
-
-
Gal-Tanamy, M.1
Keck, Z.Y.2
Yi, M.3
McKeating, J.A.4
Patel, A.H.5
Foung, S.K.6
Lemon, S.M.7
-
162
-
-
84911489136
-
Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization
-
[CrossRef] [PubMed]
-
Wong, J.A.; Bhat, R.; Hockman, D.; Logan, M.; Chen, C.; Levin, A.; Frey, S.E.; Belshe, R.B.; Tyrrell, D.L.; Law, J.L., et al. Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization. J. Virol. 2014, 88, 14278–14288. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 14278-14288
-
-
Wong, J.A.1
Bhat, R.2
Hockman, D.3
Logan, M.4
Chen, C.5
Levin, A.6
Frey, S.E.7
Belshe, R.B.8
Tyrrell, D.L.9
Law, J.L.10
-
163
-
-
84883213683
-
An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission
-
Tarr, A.W.; Lafaye, P.; Meredith, L.; Damier-Piolle, L.; Urbanowicz, R.A.; Meola, A.; Jestin, J.L.; Brown, R.J.; McKeating, J.A.; Rey, F.A., et al. An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission. Hepatology 2013, 58, 932–939. [CrossRef] [PubMed]
-
(2013)
Hepatology
, vol.58
, pp. 932-939
-
-
Tarr, A.W.1
Lafaye, P.2
Meredith, L.3
Damier-Piolle, L.4
Urbanowicz, R.A.5
Meola, A.6
Jestin, J.L.7
Brown, R.J.8
McKeating, J.A.9
Rey, F.A.10
-
164
-
-
84899101186
-
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses
-
[CrossRef] [PubMed]
-
Chmielewska, A.M.; Naddeo, M.; Capone, S.; Ammendola, V.; Hu, K.; Meredith, L.; Verhoye, L.; Rychlowska, M.; Rappuoli, R.; Ulmer, J.B., et al. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses. J. Virol. 2014, 88, 5502–5510. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 5502-5510
-
-
Chmielewska, A.M.1
Naddeo, M.2
Capone, S.3
Ammendola, V.4
Hu, K.5
Meredith, L.6
Verhoye, L.7
Rychlowska, M.8
Rappuoli, R.9
Ulmer, J.B.10
-
165
-
-
35348898348
-
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
-
[CrossRef] [PubMed]
-
Stamataki, Z.; Coates, S.; Evans, M.J.; Wininger, M.; Crawford, K.; Dong, C.; Fong, Y.L.; Chien, D.; Abrignani, S.; Balfe, P., et al. Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. Vaccine 2007, 25, 7773–7784. [CrossRef] [PubMed]
-
(2007)
Vaccine
, vol.25
, pp. 7773-7784
-
-
Stamataki, Z.1
Coates, S.2
Evans, M.J.3
Wininger, M.4
Crawford, K.5
Dong, C.6
Fong, Y.L.7
Chien, D.8
Abrignani, S.9
Balfe, P.10
-
166
-
-
80051721226
-
Immunization of human volunteers with hepatitis C virus envelope glycoproteins elicits antibodies that cross-neutralize heterologous virus strains
-
[CrossRef] [PubMed]
-
Stamataki, Z.; Coates, S.; Abrignani, S.; Houghton, M.; McKeating, J.A. Immunization of human volunteers with hepatitis C virus envelope glycoproteins elicits antibodies that cross-neutralize heterologous virus strains. J. Infect. Dis. 2011, 204, 811–813. [CrossRef] [PubMed]
-
(2011)
J. Infect. Dis
, vol.204
, pp. 811-813
-
-
Stamataki, Z.1
Coates, S.2
Abrignani, S.3
Houghton, M.4
McKeating, J.A.5
-
167
-
-
80052186961
-
Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies
-
[CrossRef] [PubMed]
-
Verstrepen, B.E.; Depla, E.; Rollier, C.S.; Mares, G.; Drexhage, J.A.; Priem, S.; Verschoor, E.J.; Koopman, G.; Granier, C.; Dreux, M., et al. Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies. J. Infect. Dis. 2011, 204, 837–844. [CrossRef] [PubMed]
-
(2011)
J. Infect. Dis
, vol.204
, pp. 837-844
-
-
Verstrepen, B.E.1
Depla, E.2
Rollier, C.S.3
Mares, G.4
Drexhage, J.A.5
Priem, S.6
Verschoor, E.J.7
Koopman, G.8
Granier, C.9
Dreux, M.10
-
168
-
-
84906330457
-
Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex
-
[CrossRef] [PubMed]
-
Ruwona, T.B.; Giang, E.; Nieusma, T.; Law, M. Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex. J. Virol. 2014, 88, 10459–10471. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 10459-10471
-
-
Ruwona, T.B.1
Giang, E.2
Nieusma, T.3
Law, M.4
-
169
-
-
33645310928
-
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
-
[CrossRef] [PubMed]
-
Tarr, A.W.; Owsianka, A.M.; Timms, J.M.; McClure, C.P.; Brown, R.J.; Hickling, T.P.; Pietschmann, T.; Bartenschlager, R.; Patel, A.H.; Ball, J.K. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33. Hepatology 2006, 43, 592–601. [CrossRef] [PubMed]
-
(2006)
Hepatology
, vol.43
, pp. 592-601
-
-
Tarr, A.W.1
Owsianka, A.M.2
Timms, J.M.3
McClure, C.P.4
Brown, R.J.5
Hickling, T.P.6
Pietschmann, T.7
Bartenschlager, R.8
Patel, A.H.9
Ball, J.K.10
-
170
-
-
34547098102
-
The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein
-
[CrossRef] [PubMed]
-
Helle, F.; Goffard, A.; Morel, V.; Duverlie, G.; McKeating, J.; Keck, Z.Y.; Foung, S.; Penin, F.; Dubuisson, J.; Voisset, C. The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J. Virol. 2007, 81, 8101–8111. [CrossRef] [PubMed]
-
(2007)
J. Virol
, vol.81
, pp. 8101-8111
-
-
Helle, F.1
Goffard, A.2
Morel, V.3
Duverlie, G.4
McKeating, J.5
Keck, Z.Y.6
Foung, S.7
Penin, F.8
Dubuisson, J.9
Voisset, C.10
-
171
-
-
84877720407
-
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is amechanism for escape from broadly neutralizing antibodies
-
[CrossRef] [PubMed]
-
Pantua, H.; Diao, J.; Ultsch, M.; Hazen, M.; Mathieu, M.; McCutcheon, K.; Takeda, K.; Date, S.; Cheung, T.K.; Phung, Q., et al. Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies. J. Mol. Biol. 2013, 425, 1899–1914. [CrossRef] [PubMed]
-
(2013)
J. Mol. Biol
, vol.425
, pp. 1899-1914
-
-
Pantua, H.1
Diao, J.2
Ultsch, M.3
Hazen, M.4
Mathieu, M.5
McCutcheon, K.6
Takeda, K.7
Date, S.8
Cheung, T.K.9
Phung, Q.10
-
172
-
-
84888588967
-
Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization
-
[CrossRef] [PubMed]
-
Anjum, S.; Wahid, A.; Afzal, M.S.; Albecka, A.; Alsaleh, K.; Ahmad, T.; Baumert, T.F.; Wychowski, C.; Qadri, I.; Penin, F., et al. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization. J. Infect. Dis. 2013, 208, 1888–1897. [CrossRef] [PubMed]
-
(2013)
J. Infect. Dis
, vol.208
, pp. 1888-1897
-
-
Anjum, S.1
Wahid, A.2
Afzal, M.S.3
Albecka, A.4
Alsaleh, K.5
Ahmad, T.6
Baumert, T.F.7
Wychowski, C.8
Qadri, I.9
Penin, F.10
-
173
-
-
33748740828
-
Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans
-
[CrossRef] [PubMed]
-
Helle, F.; Wychowski, C.; Vu-Dac, N.; Gustafson, K.R.; Voisset, C.; Dubuisson, J. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J. Biol. Chem. 2006, 281, 25177–25183. [CrossRef] [PubMed]
-
(2006)
J. Biol. Chem
, vol.281
, pp. 25177-25183
-
-
Helle, F.1
Wychowski, C.2
Vu-Dac, N.3
Gustafson, K.R.4
Voisset, C.5
Dubuisson, J.6
-
174
-
-
84889241787
-
Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: Mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA
-
[CrossRef] [PubMed]
-
Kachko, A.; Loesgen, S.; Shahzad-Ul-Hussan, S.; Tan, W.; Zubkova, I.; Takeda, K.; Wells, F.; Rubin, S.; Bewley, C.A.; Major, M.E. Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: Mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA. Mol. Pharm. 2013, 10, 4590–4602. [CrossRef] [PubMed]
-
(2013)
Mol. Pharm
, vol.10
, pp. 4590-4602
-
-
Kachko, A.1
Loesgen, S.2
Shahzad-Ul-Hussan, S.3
Tan, W.4
Zubkova, I.5
Takeda, K.6
Wells, F.7
Rubin, S.8
Bewley, C.A.9
Major, M.E.10
-
175
-
-
84906937351
-
Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
-
[CrossRef] [PubMed]
-
Hamed, M.R.; Brown, R.J.; Zothner, C.; Urbanowicz, R.A.; Mason, C.P.; Krarup, A.; McClure, C.P.; Irving, W.L.; Ball, J.K.; Harris, M., et al. Recombinant human L-ficolin directly neutralizes hepatitis C virus entry. J. Innate Immun. 2014, 6, 676–684. [CrossRef] [PubMed]
-
(2014)
J. Innate Immun
, vol.6
, pp. 676-684
-
-
Hamed, M.R.1
Brown, R.J.2
Zothner, C.3
Urbanowicz, R.A.4
Mason, C.P.5
Krarup, A.6
McClure, C.P.7
Irving, W.L.8
Ball, J.K.9
Harris, M.10
-
176
-
-
84904262489
-
Ficolin-2 inhibits hepatitis C virus infection, whereas apolipoprotein E3 mediates viral immune escape
-
[CrossRef] [PubMed]
-
Zhao, Y.; Ren, Y.; Zhang, X.; Zhao, P.; Tao, W.; Zhong, J.; Li, Q.; Zhang, X.L. Ficolin-2 inhibits hepatitis C virus infection, whereas apolipoprotein E3 mediates viral immune escape. J. Immunol. 2014, 193, 783–796. [CrossRef] [PubMed]
-
(2014)
J. Immunol
, vol.193
, pp. 783-796
-
-
Zhao, Y.1
Ren, Y.2
Zhang, X.3
Zhao, P.4
Tao, W.5
Zhong, J.6
Li, Q.7
Zhang, X.L.8
-
177
-
-
84866141721
-
Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps
-
[CrossRef] [PubMed]
-
Dao Thi, V.L.; Granier, C.; Zeisel, M.B.; Guerin, M.; Mancip, J.; Granio, O.; Penin, F.; Lavillette, D.; Bartenschlager, R.; Baumert, T.F., et al. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. J. Biol. Chem. 2012, 287, 31242–31257. [CrossRef] [PubMed]
-
(2012)
J. Biol. Chem
, vol.287
, pp. 31242-31257
-
-
Dao Thi, V.L.1
Granier, C.2
Zeisel, M.B.3
Guerin, M.4
Mancip, J.5
Granio, O.6
Penin, F.7
Lavillette, D.8
Bartenschlager, R.9
Baumert, T.F.10
-
178
-
-
84864139370
-
Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate
-
[CrossRef] [PubMed]
-
Jiang, J.; Cun, W.; Wu, X.; Shi, Q.; Tang, H.; Luo, G. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J. Virol. 2012, 86, 7256–7267. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 7256-7267
-
-
Jiang, J.1
Cun, W.2
Wu, X.3
Shi, Q.4
Tang, H.5
Luo, G.6
-
179
-
-
35448974889
-
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus
-
[CrossRef] [PubMed]
-
Dreux, M.; Boson, B.; Ricard-Blum, S.; Molle, J.; Lavillette, D.; Bartosch, B.; Pecheur, E.I.; Cosset, F.L. The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. J. Biol. Chem. 2007, 282, 32357–32369. [CrossRef] [PubMed]
-
(2007)
J. Biol. Chem
, vol.282
, pp. 32357-32369
-
-
Dreux, M.1
Boson, B.2
Ricard-Blum, S.3
Molle, J.4
Lavillette, D.5
Bartosch, B.6
Pecheur, E.I.7
Cosset, F.L.8
-
180
-
-
33747354847
-
High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry
-
[CrossRef] [PubMed]
-
Voisset, C.; Op de Beeck, A.; Horellou, P.; Dreux, M.; Gustot, T.; Duverlie, G.; Cosset, F.L.; Vu-Dac, N.; Dubuisson, J. High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. J. Gen. Virol. 2006, 87, 2577–2581. [CrossRef] [PubMed]
-
(2006)
J. Gen. Virol
, vol.87
, pp. 2577-2581
-
-
Voisset, C.1
De Op Beeck, A.2
Horellou, P.3
Dreux, M.4
Gustot, T.5
Duverlie, G.6
Cosset, F.L.7
Vu-Dac, N.8
Dubuisson, J.9
-
181
-
-
33745863032
-
High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI
-
[CrossRef] [PubMed]
-
Dreux, M.; Pietschmann, T.; Granier, C.; Voisset, C.; Ricard-Blum, S.; Mangeot, P.E.; Keck, Z.; Foung, S.; Vu-Dac, N.; Dubuisson, J., et al. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J. Biol. Chem. 2006, 281, 18285–18295. [CrossRef] [PubMed]
-
(2006)
J. Biol. Chem
, vol.281
, pp. 18285-18295
-
-
Dreux, M.1
Pietschmann, T.2
Granier, C.3
Voisset, C.4
Ricard-Blum, S.5
Mangeot, P.E.6
Keck, Z.7
Foung, S.8
Vu-Dac, N.9
Dubuisson, J.10
-
182
-
-
78650048403
-
Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission
-
[CrossRef] [PubMed]
-
Brimacombe, C.L.; Grove, J.; Meredith, L.W.; Hu, K.; Syder, A.J.; Flores, M.V.; Timpe, J.M.; Krieger, S.E.; Baumert, T.F.; Tellinghuisen, T.L., et al. Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J. Virol. 2011, 85, 596–605. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 596-605
-
-
Brimacombe, C.L.1
Grove, J.2
Meredith, L.W.3
Hu, K.4
Syder, A.J.5
Flores, M.V.6
Timpe, J.M.7
Krieger, S.E.8
Baumert, T.F.9
Tellinghuisen, T.L.10
-
183
-
-
59849121683
-
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
-
[CrossRef] [PubMed]
-
Witteveldt, J.; Evans, M.J.; Bitzegeio, J.; Koutsoudakis, G.; Owsianka, A.M.; Angus, A.G.; Keck, Z.Y.; Foung, S.K.; Pietschmann, T.; Rice, C.M., et al. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J. Gen. Virol. 2009, 90, 48–58. [CrossRef] [PubMed]
-
(2009)
J. Gen. Virol
, vol.90
, pp. 48-58
-
-
Witteveldt, J.1
Evans, M.J.2
Bitzegeio, J.3
Koutsoudakis, G.4
Owsianka, A.M.5
Angus, A.G.6
Keck, Z.Y.7
Foung, S.K.8
Pietschmann, T.9
Rice, C.M.10
-
184
-
-
38649100951
-
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
-
[CrossRef] [PubMed]
-
Timpe, J.M.; Stamataki, Z.; Jennings, A.; Hu, K.; Farquhar, M.J.; Harris, H.J.; Schwarz, A.; Desombere, I.; Roels, G.L.; Balfe, P., et al. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 2008, 47, 17-24. [CrossRef] [PubMed]
-
(2008)
Hepatology
, vol.47
, pp. 17-24
-
-
Timpe, J.M.1
Stamataki, Z.2
Jennings, A.3
Hu, K.4
Farquhar, M.J.5
Harris, H.J.6
Schwarz, A.7
Desombere, I.8
Roels, G.L.9
Balfe, P.10
-
185
-
-
84877923438
-
Early infection events highlight the limited transmissibility of hepatitis C virus in vitro
-
[CrossRef] [PubMed]
-
Meredith, L.W.; Harris, H.J.; Wilson, G.K.; Fletcher, N.F.; Balfe, P.; McKeating, J.A. Early infection events highlight the limited transmissibility of hepatitis C virus in vitro. J. Hepatol. 2013, 58, 1074–1080. [CrossRef] [PubMed]
-
(2013)
J. Hepatol
, vol.58
, pp. 1074-1080
-
-
Timpe, J.M.1
Stamataki, Z.2
Jennings, A.3
Hu, K.4
Farquhar, M.J.5
Harris, H.J.6
Schwarz, A.7
Desombere, I.8
Roels, G.L.9
Meredith, L.W.10
Harris, H.J.11
Wilson, G.K.12
Fletcher, N.F.13
Balfe, P.14
McKeating, J.A.15
-
186
-
-
84892473356
-
Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly
-
[CrossRef] [PubMed]
-
Hueging, K.; Doepke, M.; Vieyres, G.; Bankwitz, D.; Frentzen, A.; Doerrbecker, J.; Gumz, F.; Haid, S.; Wolk, B.; Kaderali, L., et al. Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly. J. Virol. 2014, 88, 1433–1446. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 1433-1446
-
-
Hueging, K.1
Doepke, M.2
Vieyres, G.3
Bankwitz, D.4
Frentzen, A.5
Doerrbecker, J.6
Gumz, F.7
Haid, S.8
Wolk, B.9
Kaderali, L.10
-
187
-
-
84877957589
-
A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission
-
[CrossRef] [PubMed]
-
Fofana, I.; Xiao, F.; Thumann, C.; Turek, M.; Zona, L.; Tawar, R.G.; Grunert, F.; Thompson, J.; Zeisel, M.B.; Baumert, T.F. A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission. PLoS ONE 2013, 8, e64221. [CrossRef] [PubMed]
-
(2013)
Plos ONE
, vol.8
-
-
Fofana, I.1
Xiao, F.2
Thumann, C.3
Turek, M.4
Zona, L.5
Tawar, R.G.6
Grunert, F.7
Thompson, J.8
Zeisel, M.B.9
Baumert, T.F.10
-
188
-
-
80054713474
-
A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
-
[CrossRef] [PubMed]
-
Meuleman, P.; Catanese, M.T.; Verhoye, L.; Desombere, I.; Farhoudi, A.; Jones, C.T.; Sheahan, T.; Grzyb, K.; Cortese, R.; Rice, C.M., et al. A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo. Hepatology 2012, 55, 364–372. [CrossRef] [PubMed]
-
(2012)
Hepatology
, vol.55
, pp. 364-372
-
-
Meuleman, P.1
Catanese, M.T.2
Verhoye, L.3
Desombere, I.4
Farhoudi, A.5
Jones, C.T.6
Sheahan, T.7
Grzyb, K.8
Cortese, R.9
Rice, C.M.10
-
189
-
-
84901674443
-
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
-
[CrossRef] [PubMed]
-
Xiao, F.; Fofana, I.; Heydmann, L.; Barth, H.; Soulier, E.; Habersetzer, F.; Doffoel, M.; Bukh, J.; Patel, A.H.; Zeisel, M.B., et al. Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents. PLoS Pathog. 2014, 10, e1004128. [CrossRef] [PubMed]
-
(2014)
Plos Pathog
, vol.10
-
-
Xiao, F.1
Fofana, I.2
Heydmann, L.3
Barth, H.4
Soulier, E.5
Habersetzer, F.6
Doffoel, M.7
Bukh, J.8
Patel, A.H.9
Zeisel, M.B.10
-
190
-
-
84876942110
-
Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus
-
[CrossRef] [PubMed]
-
Deng, L.; Zhong, L.; Struble, E.; Duan, H.; Ma, L.; Harman, C.; Yan, H.; Virata-Theimer, M.L.; Zhao, Z.; Feinstone, S., et al. Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus. Proc. Natl. Acad. Sci. USA 2013, 110, 7418–7422. [CrossRef] [PubMed]
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 7418-7422
-
-
Deng, L.1
Zhong, L.2
Struble, E.3
Duan, H.4
Ma, L.5
Harman, C.6
Yan, H.7
Virata-Theimer, M.L.8
Zhao, Z.9
Feinstone, S.10
-
191
-
-
66149135701
-
Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity
-
[CrossRef] [PubMed]
-
Zhang, P.; Zhong, L.; Struble, E.B.; Watanabe, H.; Kachko, A.; Mihalik, K.; Virata-Theimer, M.L.; Alter, H.J.; Feinstone, S.; Major, M. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity. Proc. Natl. Acad. Sci. USA 2009, 106, 7537–7541. [CrossRef] [PubMed]
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 7537-7541
-
-
Zhang, P.1
Zhong, L.2
Struble, E.B.3
Watanabe, H.4
Kachko, A.5
Mihalik, K.6
Virata-Theimer, M.L.7
Alter, H.J.8
Feinstone, S.9
Major, M.10
-
192
-
-
80051923476
-
A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection
-
[CrossRef] [PubMed]
-
Meyer, K.; Banerjee, A.; Frey, S.E.; Belshe, R.B.; Ray, R. A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection. PLoS ONE 2011, 6, e23699. [CrossRef] [PubMed]
-
(2011)
Plos ONE
, vol.6
-
-
Meyer, K.1
Banerjee, A.2
Frey, S.E.3
Belshe, R.B.4
Ray, R.5
-
193
-
-
39749175035
-
Antibody-dependent enhancement of hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Meyer, K.; Ait-Goughoulte, M.; Keck, Z.Y.; Foung, S.; Ray, R. Antibody-dependent enhancement of hepatitis C virus infection. J. Virol. 2008, 82, 2140–2149. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 2140-2149
-
-
Meyer, K.1
Ait-Goughoulte, M.2
Keck, Z.Y.3
Foung, S.4
Ray, R.5
-
194
-
-
84871990813
-
Cooperativity in virus neutralization by human monoclonal antibodies to two adjacentregions located at the amino terminus of hepatitis C virus E2 glycoprotein
-
[CrossRef] [PubMed]
-
Keck, Z.; Wang, W.; Wang, Y.; Lau, P.; Carlsen, T.H.; Prentoe, J.; Xia, J.; Patel, A.H.; Bukh, J.; Foung, S.K. Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein. J. Virol. 2013, 87, 37–51. [CrossRef] [PubMed]
-
(2013)
J. Virol
, vol.87
, pp. 37-51
-
-
Keck, Z.1
Wang, W.2
Wang, Y.3
Lau, P.4
Carlsen, T.H.5
Prentoe, J.6
Xia, J.7
Patel, A.H.8
Bukh, J.9
Foung, S.K.10
-
195
-
-
34347253229
-
Virus epitope-specific neutralizing antibodies in Igs prepared from human plasma
-
[CrossRef] [PubMed]
-
Zhang, P.; Wu, C.G.; Mihalik, K.; Virata-Theimer, M.L.; Yu, M.Y.; Alter, H.J.; Feinstone, S.M. Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. Proc. Natl. Acad. Sci. USA 2007, 104, 8449–8454. [CrossRef] [PubMed]
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 8449-8454
-
-
Zhang, P.1
Wu, C.G.2
Mihalik, K.3
Virata-Theimer, M.L.4
Yu, M.Y.5
Alter, H.J.6
Feinstone, S.M.7
Hepatitis, C.8
-
196
-
-
84904609849
-
Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization
-
[CrossRef] [PubMed]
-
Deng, L.; Ma, L.; Virata-Theimer, M.L.; Zhong, L.; Yan, H.; Zhao, Z.; Struble, E.; Feinstone, S.; Alter, H.; Zhang, P. Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization. Proc. Natl. Acad. Sci. USA 2014, 111, 10690–10695. [CrossRef] [PubMed]
-
(2014)
Proc. Natl. Acad. Sci. USA
, vol.111
, pp. 10690-10695
-
-
Deng, L.1
Ma, L.2
Virata-Theimer, M.L.3
Zhong, L.4
Yan, H.5
Zhao, Z.6
Struble, E.7
Feinstone, S.8
Alter, H.9
Zhang, P.10
-
197
-
-
84930159950
-
The neonatal Fc receptor does not modulate hepatitis C virus neutralization
-
[CrossRef] [PubMed]
-
Morel, A.; Passot, C.; Arnoult, C.; Dumans, A.; Beaumont, E.; Gouilleux-Gruart, V.; Roingeard, P.; Blanchard, E. The neonatal Fc receptor does not modulate hepatitis C virus neutralization. J. Gen. Virol. 2015, 96, 1062–1066. [CrossRef] [PubMed]
-
(2015)
J. Gen. Virol
, vol.96
, pp. 1062-1066
-
-
Morel, A.1
Passot, C.2
Arnoult, C.3
Dumans, A.4
Beaumont, E.5
Gouilleux-Gruart, V.6
Roingeard, P.7
Blanchard, E.8
-
198
-
-
34147219730
-
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
-
[CrossRef] [PubMed]
-
Evans, M.J.; von Hahn, T.; Tscherne, D.M.; Syder, A.J.; Panis, M.; Wolk, B.; Hatziioannou, T.; McKeating, J.A.; Bieniasz, P.D.; Rice, C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007, 446, 801–805. [CrossRef] [PubMed]
-
(2007)
Nature
, vol.446
, pp. 801-805
-
-
Evans, M.J.1
Von Hahn, T.2
Tscherne, D.M.3
Syder, A.J.4
Panis, M.5
Wolk, B.6
Hatziioannou, T.7
McKeating, J.A.8
Bieniasz, P.D.9
Rice, C.M.10
-
199
-
-
60149090028
-
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
-
[CrossRef] [PubMed]
-
Ploss, A.; Evans, M.J.; Gaysinskaya, V.A.; Panis, M.; You, H.; de Jong, Y.P.; Rice, C.M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009, 457, 882–886. [CrossRef] [PubMed]
-
(2009)
Nature
, vol.457
, pp. 882-886
-
-
Ploss, A.1
Evans, M.J.2
Gaysinskaya, V.A.3
Panis, M.4
You, H.5
De Jong, Y.P.6
Rice, C.M.7
-
200
-
-
17044457135
-
Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate
-
[CrossRef] [PubMed]
-
Barth, H.; Schafer, C.; Adah, M.I.; Zhang, F.; Linhardt, R.J.; Toyoda, H.; Kinoshita-Toyoda, A.; Toida, T.; van Kuppevelt, T.H.; Depla, E., et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 2003, 278, 41003–41012. [CrossRef] [PubMed]
-
(2003)
J. Biol. Chem
, vol.278
, pp. 41003-41012
-
-
Barth, H.1
Schafer, C.2
Adah, M.I.3
Zhang, F.4
Linhardt, R.J.5
Toyoda, H.6
Kinoshita-Toyoda, A.7
Toida, T.8
Van Kuppevelt, T.H.9
Depla, E.10
-
201
-
-
33646743366
-
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses
-
[CrossRef] [PubMed]
-
Koutsoudakis, G.; Kaul, A.; Steinmann, E.; Kallis, S.; Lohmann, V.; Pietschmann, T.; Bartenschlager, R. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 2006, 80, 5308–5320. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 5308-5320
-
-
Koutsoudakis, G.1
Kaul, A.2
Steinmann, E.3
Kallis, S.4
Lohmann, V.5
Pietschmann, T.6
Bartenschlager, R.7
-
202
-
-
0033607281
-
Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
-
[CrossRef] [PubMed]
-
Agnello, V.; Abel, G.; Elfahal, M.; Knight, G.B.; Zhang, Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 1999, 96, 12766–12771. [CrossRef] [PubMed]
-
(1999)
. Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 12766-12771
-
-
Agnello, V.1
Abel, G.2
Elfahal, M.3
Knight, G.B.4
Zhang, Q.X.5
-
203
-
-
79955692689
-
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
-
[CrossRef] [PubMed]
-
Lupberger, J.; Zeisel, M.B.; Xiao, F.; Thumann, C.; Fofana, I.; Zona, L.; Davis, C.; Mee, C.J.; Turek, M.; Gorke, S., et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 2011, 17, 589–595. [CrossRef] [PubMed]
-
(2011)
Nat. Med
, vol.17
, pp. 589-595
-
-
Lupberger, J.1
Zeisel, M.B.2
Xiao, F.3
Thumann, C.4
Fofana, I.5
Zona, L.6
Davis, C.7
Mee, C.J.8
Turek, M.9
Gorke, S.10
-
204
-
-
84856732297
-
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
-
[CrossRef] [PubMed]
-
Sainz, B., Jr.; Barretto, N.; Martin, D.N.; Hiraga, N.; Imamura, M.; Hussain, S.; Marsh, K.A.; Yu, X.; Chayama, K.; Alrefai, W.A., et al. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 2012, 18, 281–285. [CrossRef] [PubMed]
-
(2012)
Nat. Med
, vol.18
, pp. 281-285
-
-
Sainz, B.1
Barretto, N.2
Martin, D.N.3
Hiraga, N.4
Imamura, M.5
Hussain, S.6
Marsh, K.A.7
Yu, X.8
Chayama, K.9
Alrefai, W.A.10
-
205
-
-
84875125387
-
HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex
-
[CrossRef] [PubMed]
-
Zona, L.; Lupberger, J.; Sidahmed-Adrar, N.; Thumann, C.; Harris, H.J.; Barnes, A.; Florentin, J.; Tawar, R.G.; Xiao, F.; Turek, M., et al. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host Microbe 2013, 13, 302–313. [CrossRef] [PubMed]
-
(2013)
Cell Host Microbe
, vol.13
, pp. 302-313
-
-
Zona, L.1
Lupberger, J.2
Sidahmed-Adrar, N.3
Thumann, C.4
Harris, H.J.5
Barnes, A.6
Florentin, J.7
Tawar, R.G.8
Xiao, F.9
Turek, M.10
-
206
-
-
84879549180
-
Identification of transferrin receptor 1 as a hepatitis C virus entry factor
-
[CrossRef] [PubMed]
-
Martin, D.N.; Uprichard, L. Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc. Natl. Acad. Sci. USA 2013, 110, 10777–10782. [CrossRef] [PubMed]
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 10777-10782
-
-
Martin, D.N.1
Uprichard, L.2
-
207
-
-
84903883619
-
Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes
-
[CrossRef] [PubMed]
-
Wu, X.; Lee, E.M.; Hammack, C.; Robotham, J.M.; Basu, M.; Lang, J.; Brinton, M.A.; Tang, H. Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes. J. Virol. 2014, 88, 8433–8444. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 8433-8444
-
-
Wu, X.1
Lee, E.M.2
Hammack, C.3
Robotham, J.M.4
Basu, M.5
Lang, J.6
Brinton, M.A.7
Tang, H.8
-
208
-
-
84901688047
-
Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle
-
[CrossRef] [PubMed]
-
Li, Q.; Zhang, Y.Y.; Chiu, S.; Hu, Z.; Lan, K.H.; Cha, H.; Sodroski, C.; Zhang, F.; Hsu, C.S.; Thomas, E., et al. Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle. PLoS Pathog. 2014, 10, e1004163. [CrossRef] [PubMed]
-
(2014)
Plos Pathog
, vol.10
-
-
Li, Q.1
Zhang, Y.Y.2
Chiu, S.3
Hu, Z.4
Lan, K.H.5
Cha, H.6
Sodroski, C.7
Zhang, F.8
Hsu, C.S.9
Thomas, E.10
-
209
-
-
19044396066
-
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles
-
[CrossRef] [PubMed]
-
Andre, P.; Komurian-Pradel, F.; Deforges, S.; Perret, M.; Berland, J.L.; Sodoyer, M.; Pol, S.; Brechot, C.; Paranhos-Baccala, G.; Lotteau, V. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 2002, 76, 6919–6928. [CrossRef] [PubMed]
-
(2002)
J. Virol
, vol.76
, pp. 6919-6928
-
-
Andre, P.1
Komurian-Pradel, F.2
Deforges, S.3
Perret, M.4
Berland, J.L.5
Sodoyer, M.6
Pol, S.7
Brechot, C.8
Paranhos-Baccala, G.9
Lotteau, V.10
-
210
-
-
33144465371
-
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients
-
[CrossRef] [PubMed]
-
Nielsen, S.U.; Bassendine, M.F.; Burt, A.D.; Martin, C.; Pumeechockchai, W.; Toms, G.L. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J. Virol. 2006, 80, 2418–2428. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 2418-2428
-
-
Nielsen, S.U.1
Bassendine, M.F.2
Burt, A.D.3
Martin, C.4
Pumeechockchai, W.5
Toms, G.L.6
-
211
-
-
0026447722
-
Association of hepatitis C virus in human sera with beta-lipoprotein
-
[CrossRef] [PubMed]
-
Thomssen, R.; Bonk, S.; Propfe, C.; Heermann, K.H.; Kochel, H.G.; Uy, A. Association of hepatitis C virus in human sera with beta-lipoprotein. Med. Microbiol. Immunol. 1992, 181, 293–300. [CrossRef] [PubMed]
-
(1992)
Med. Microbiol. Immunol
, vol.181
, pp. 293-300
-
-
Thomssen, R.1
Bonk, S.2
Propfe, C.3
Heermann, K.H.4
Kochel, H.G.5
Uy, A.6
-
212
-
-
78951472169
-
Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome
-
[CrossRef] [PubMed]
-
Merz, A.; Long, G.; Hiet, M.S.; Brugger, B.; Chlanda, P.; Andre, P.; Wieland, F.; Krijnse-Locker, J.; Bartenschlager, R. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J. Biol. Chem. 2011, 286, 3018–3032. [CrossRef] [PubMed]
-
(2011)
J. Biol. Chem
, vol.286
, pp. 3018-3032
-
-
Merz, A.1
Long, G.2
Hiet, M.S.3
Brugger, B.4
Chlanda, P.5
Andre, P.6
Wieland, F.7
Krijnse-Locker, J.8
Bartenschlager, R.9
-
213
-
-
70350124913
-
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor
-
[CrossRef] [PubMed]
-
Owen, D.M.; Huang, H.; Ye, J.; Gale, M., Jr. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 2009, 394, 99–108. [CrossRef] [PubMed]
-
(2009)
Virology
, vol.394
, pp. 99-108
-
-
Owen, D.M.1
Huang, H.2
Ye, J.3
Gale, M.4
-
214
-
-
78049518684
-
Infectivity of hepatitis C virus is influenced by association with apolipoprotein
-
[CrossRef] [PubMed]
-
Hishiki, T.; Shimizu, Y.; Tobita, R.; Sugiyama, K.; Ogawa, K.; Funami, K.; Ohsaki, Y.; Fujimoto, T.; Takaku, H.; Wakita, T., et al. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J. Virol. 2010, 84, 12048–12057. [CrossRef] [PubMed]
-
(2010)
E Isoforms. J. Virol
, vol.84
, pp. 12048-12057
-
-
Hishiki, T.1
Shimizu, Y.2
Tobita, R.3
Sugiyama, K.4
Ogawa, K.5
Funami, K.6
Ohsaki, Y.7
Fujimoto, T.8
Takaku, H.9
Wakita, T.10
-
215
-
-
33646255673
-
The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins
-
[CrossRef] [PubMed]
-
Maillard, P.; Huby, T.; Andreo, U.; Moreau, M.; Chapman, J.; Budkowska, A. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J. 2006, 20, 735–737. [CrossRef] [PubMed]
-
(2006)
FASEB J
, vol.20
, pp. 735-737
-
-
Maillard, P.1
Huby, T.2
Andreo, U.3
Moreau, M.4
Chapman, J.5
Budkowska, A.6
-
216
-
-
37049007864
-
Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture
-
[CrossRef] [PubMed]
-
Chang, K.S.; Jiang, J.; Cai, Z.; Luo, G. Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J. Virol. 2007, 81, 13783–13793. [CrossRef] [PubMed]
-
(2007)
J. Virol
, vol.81
, pp. 13783-13793
-
-
Chang, K.S.1
Jiang, J.2
Cai, Z.3
Luo, G.4
-
217
-
-
61949320778
-
Development and characterization of hepatitis C virus genotype 1–7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs
-
[CrossRef] [PubMed]
-
Gottwein, J.M.; Scheel, T.K.; Jensen, T.B.; Lademann, J.B.; Prentoe, J.C.; Knudsen, M.L.; Hoegh, A.M.; Bukh, J. Development and characterization of hepatitis C virus genotype 1–7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 2009, 49, 364–377. [CrossRef] [PubMed]
-
(2009)
Hepatology
, vol.49
, pp. 364-377
-
-
Gottwein, J.M.1
Scheel, T.K.2
Jensen, T.B.3
Lademann, J.B.4
Prentoe, J.C.5
Knudsen, M.L.6
Hoegh, A.M.7
Bukh, J.8
-
218
-
-
36048954580
-
Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus
-
[CrossRef] [PubMed]
-
Zheng, A.; Yuan, F.; Li, Y.; Zhu, F.; Hou, P.; Li, J.; Song, X.; Ding, M.; Deng, H. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. J. Virol. 2007, 81, 12465–12471. [CrossRef] [PubMed]
-
(2007)
J. Virol
, vol.81
, pp. 12465-12471
-
-
Zheng, A.1
Yuan, F.2
Li, Y.3
Zhu, F.4
Hou, P.5
Li, J.6
Song, X.7
Ding, M.8
Deng, H.9
-
219
-
-
41149117446
-
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus
-
[CrossRef] [PubMed]
-
Meertens, L.; Bertaux, C.; Cukierman, L.; Cormier, E.; Lavillette, D.; Cosset, F.L.; Dragic, T. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus. J. Virol. 2008, 82, 3555–3560. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 3555-3560
-
-
Meertens, L.1
Bertaux, C.2
Cukierman, L.3
Cormier, E.4
Lavillette, D.5
Cosset, F.L.6
Dragic, T.7
-
220
-
-
84894626680
-
Isolate-dependent use of claudins for cell entry by hepatitis C virus
-
[CrossRef] [PubMed]
-
Haid, S.; Grethe, C.; Dill, M.T.; Heim, M.; Kaderali, L.; Pietschmann, T. Isolate-dependent use of claudins for cell entry by hepatitis C virus. Hepatology 2014, 59, 24–34. [CrossRef] [PubMed]
-
(2014)
Hepatology
, vol.59
, pp. 24-34
-
-
Haid, S.1
Grethe, C.2
Dill, M.T.3
Heim, M.4
Kaderali, L.5
Pietschmann, T.6
-
221
-
-
84942552545
-
Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins
-
[CrossRef] [PubMed]
-
Hopcraft, S.E.; Evans, M.J. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins. Hepatology 2015. [CrossRef] [PubMed]
-
(2015)
Hepatology
-
-
Hopcraft, S.E.1
Evans, M.J.2
-
222
-
-
84875978697
-
Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies
-
[CrossRef] [PubMed]
-
Sourisseau, M.; Michta, M.L.; Zony, C.; Israelow, B.; Hopcraft, S.E.; Narbus, C.M.; Parra Martin, A.; Evans, M.J. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLoS Pathog. 2013, 9, e1003244. [CrossRef] [PubMed]
-
(2013)
Plos Pathog
, vol.9
-
-
Sourisseau, M.1
Michta, M.L.2
Zony, C.3
Israelow, B.4
Hopcraft, S.E.5
Narbus, C.M.6
Parra Martin, A.7
Evans, M.J.8
-
223
-
-
33750740163
-
Persistent hepatitis C virus infection in vitro: Coevolution of virus and host
-
[CrossRef] [PubMed]
-
Zhong, J.; Gastaminza, P.; Chung, J.; Stamataki, Z.; Isogawa, M.; Cheng, G.; McKeating, J.A.; Chisari, F.V. Persistent hepatitis C virus infection in vitro: Coevolution of virus and host. J. Virol. 2006, 80, 11082–11093. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 11082-11093
-
-
Zhong, J.1
Gastaminza, P.2
Chung, J.3
Stamataki, Z.4
Isogawa, M.5
Cheng, G.6
McKeating, J.A.7
Chisari, F.V.8
-
224
-
-
71749087885
-
A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles
-
[CrossRef] [PubMed]
-
Tao, W.; Xu, C.; Ding, Q.; Li, R.; Xiang, Y.; Chung, J.; Zhong, J. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles. Virology 2009, 395, 67–76. [CrossRef] [PubMed]
-
(2009)
Virology
, vol.395
, pp. 67-76
-
-
Tao, W.1
Xu, C.2
Ding, Q.3
Li, R.4
Xiang, Y.5
Chung, J.6
Zhong, J.7
-
225
-
-
78651244199
-
The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity
-
[CrossRef] [PubMed]
-
McCaffrey, K.; Gouklani, H.; Boo, I.; Poumbourios, P.; Drummer, H.E. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity. J. Gen. Virol. 2011, 92, 112–121. [CrossRef] [PubMed]
-
(2011)
J. Gen. Virol
, vol.92
, pp. 112-121
-
-
McCaffrey, K.1
Gouklani, H.2
Boo, I.3
Poumbourios, P.4
Drummer, H.E.5
-
226
-
-
0034700083
-
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees
-
[CrossRef] [PubMed]
-
Forns, X.; Thimme, R.; Govindarajan, S.; Emerson, S.U.; Purcell, R.H.; Chisari, F.V.; Bukh, J. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc. Natl. Acad. Sci. USA 2000, 97, 13318–13323. [CrossRef] [PubMed]
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 13318-13323
-
-
Forns, X.1
Thimme, R.2
Govindarajan, S.3
Emerson, S.U.4
Purcell, R.H.5
Chisari, F.V.6
Bukh, J.7
-
227
-
-
84892452345
-
Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus
-
[CrossRef] [PubMed]
-
Prentoe, J.; Serre, S.B.; Ramirez, S.; Nicosia, A.; Gottwein, J.M.; Bukh, J. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus. J. Virol. 2014, 88, 1725–1739. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 1725-1739
-
-
Prentoe, J.1
Serre, S.B.2
Ramirez, S.3
Nicosia, A.4
Gottwein, J.M.5
Bukh, J.6
-
228
-
-
79551700091
-
Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization
-
[CrossRef] [PubMed]
-
Prentoe, J.; Jensen, T.B.; Meuleman, P.; Serre, S.B.; Scheel, T.K.; Leroux-Roels, G.; Gottwein, J.M.; Bukh, J. Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization. J. Virol. 2011, 85, 2224–2234. [CrossRef] [PubMed]
-
(2011)
J. Virol
, vol.85
, pp. 2224-2234
-
-
Prentoe, J.1
Jensen, T.B.2
Meuleman, P.3
Serre, S.B.4
Scheel, T.K.5
Leroux-Roels, G.6
Gottwein, J.M.7
Bukh, J.8
-
229
-
-
84913554793
-
HCV animal models and liver disease
-
[CrossRef] [PubMed]
-
Vercauteren, K.; de Jong, Y.P.; Meuleman, P. HCV animal models and liver disease. J. Hepatol. 2014, 61 (Suppl. S1), S26–S33. [CrossRef] [PubMed]
-
(2014)
J. Hepatol
, vol.61
-
-
Vercauteren, K.1
De Jong, Y.P.2
Meuleman, P.3
-
230
-
-
33750706590
-
Diverse CD81 proteins support hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Flint, M.; von Hahn, T.; Zhang, J.; Farquhar, M.; Jones, C.T.; Balfe, P.; Rice, C.M.; McKeating, J.A. Diverse CD81 proteins support hepatitis C virus infection. J. Virol. 2006, 80, 11331–11342. [CrossRef] [PubMed]
-
(2006)
J. Virol
, vol.80
, pp. 11331-11342
-
-
Flint, M.1
Von Hahn, T.2
Zhang, J.3
Farquhar, M.4
Jones, C.T.5
Balfe, P.6
Rice, C.M.7
McKeating, J.A.8
-
231
-
-
78049517788
-
Species-specific regions of occludin required by hepatitis C virus for cell entry
-
[CrossRef] [PubMed]
-
Michta, M.L.; Hopcraft, S.E.; Narbus, C.M.; Kratovac, Z.; Israelow, B.; Sourisseau, M.; Evans, M.J. Species-specific regions of occludin required by hepatitis C virus for cell entry. J. Virol. 2010, 84, 11696–11708. [CrossRef] [PubMed]
-
(2010)
J. Virol
, vol.84
, pp. 11696-11708
-
-
Michta, M.L.1
Hopcraft, S.E.2
Narbus, C.M.3
Kratovac, Z.4
Israelow, B.5
Sourisseau, M.6
Evans, M.J.7
-
232
-
-
77957660356
-
Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors
-
[CrossRef] [PubMed]
-
Bitzegeio, J.; Bankwitz, D.; Hueging, K.; Haid, S.; Brohm, C.; Zeisel, M.B.; Herrmann, E.; Iken, M.; Ott, M.; Baumert, T.F., et al. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathog. 2010, 6, e1000978. [CrossRef] [PubMed]
-
(2010)
Plos Pathog
, vol.6
-
-
Bitzegeio, J.1
Bankwitz, D.2
Hueging, K.3
Haid, S.4
Brohm, C.5
Zeisel, M.B.6
Herrmann, E.7
Iken, M.8
Ott, M.9
Baumert, T.F.10
-
233
-
-
84886772600
-
Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Sourisseau, M.; Goldman, O.; He, W.; Gori, J.L.; Kiem, H.P.; Gouon-Evans, V.; Evans, M.J. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection. Gastroenterology 2013, 145, 966–969. [CrossRef] [PubMed]
-
(2013)
Gastroenterology
, vol.145
, pp. 966-969
-
-
Sourisseau, M.1
Goldman, O.2
He, W.3
Gori, J.L.4
Kiem, H.P.5
Gouon-Evans, V.6
Evans, M.J.7
-
234
-
-
42949130180
-
Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly
-
[CrossRef] [PubMed]
-
Appel, N.; Zayas, M.; Miller, S.; Krijnse-Locker, J.; Schaller, T.; Friebe, P.; Kallis, S.; Engel, U.; Bartenschlager, R. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008, 4, e1000035. [CrossRef] [PubMed]
-
(2008)
Plos Pathog
, vol.4
-
-
Appel, N.1
Zayas, M.2
Miller, S.3
Krijnse-Locker, J.4
Schaller, T.5
Friebe, P.6
Kallis, S.7
Engel, U.8
Bartenschlager, R.9
-
235
-
-
84866156581
-
Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus
-
[CrossRef] [PubMed]
-
Jiang, J.; Luo, G. Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus. J. Virol. 2012, 86, 8987–8997. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 8987-8997
-
-
Jiang, J.1
Luo, G.2
-
236
-
-
34547734952
-
Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus
-
[CrossRef] [PubMed]
-
Jones, C.T.; Murray, C.L.; Eastman, D.K.; Tassello, J.; Rice, C.M. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 2007, 81, 8374–8383. [CrossRef] [PubMed]
-
(2007)
J. Virol
, vol.81
, pp. 8374-8383
-
-
Jones, C.T.1
Murray, C.L.2
Eastman, D.K.3
Tassello, J.4
Rice, C.M.5
-
237
-
-
60049083503
-
The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus
-
[CrossRef] [PubMed]
-
Jones, D.M.; Patel, A.H.; Targett-Adams, P.; McLauchlan, J. The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus. J. Virol. 2009, 83, 2163–2177. [CrossRef] [PubMed]
-
(2009)
J. Virol
, vol.83
, pp. 2163-2177
-
-
Jones, D.M.1
Patel, A.H.2
Targett-Adams, P.3
McLauchlan, J.4
-
238
-
-
47749092840
-
NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly
-
[CrossRef] [PubMed]
-
Ma, Y.; Yates, J.; Liang, Y.; Lemon, S.M.; Yi, M. NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J. Virol. 2008, 82, 7624–7639. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 7624-7639
-
-
Ma, Y.1
Yates, J.2
Liang, Y.3
Lemon, S.M.4
Yi, M.5
-
239
-
-
69249231061
-
Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes
-
[CrossRef] [PubMed]
-
Phan, T.; Beran, R.K.; Peters, C.; Lorenz, I.C.; Lindenbach, B.D. Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J. Virol. 2009, 83, 8379–8395. [CrossRef] [PubMed]
-
(2009)
J. Virol
, vol.83
, pp. 8379-8395
-
-
Phan, T.1
Beran, R.K.2
Peters, C.3
Lorenz, I.C.4
Lindenbach, B.D.5
-
240
-
-
34547616693
-
Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions
-
[CrossRef] [PubMed]
-
Steinmann, E.; Penin, F.; Kallis, S.; Patel, A.H.; Bartenschlager, R.; Pietschmann, T. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog. 2007, 3, e103. [CrossRef] [PubMed]
-
(2007)
Plos Pathog
, vol.3
-
-
Steinmann, E.1
Penin, F.2
Kallis, S.3
Patel, A.H.4
Bartenschlager, R.5
Pietschmann, T.6
-
241
-
-
33846111662
-
Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus
-
[CrossRef] [PubMed]
-
Yi, M.; Ma, Y.; Yates, J.; Lemon, S.M. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J. Virol. 2007, 81, 629–638. [CrossRef] [PubMed]
-
(2007)
J. Virol
, vol.81
, pp. 629-638
-
-
Yi, M.1
Ma, Y.2
Yates, J.3
Lemon, S.M.4
-
242
-
-
39749098739
-
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion
-
[CrossRef] [PubMed]
-
Gastaminza, P.; Cheng, G.; Wieland, S.; Zhong, J.; Liao, W.; Chisari, F.V. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 2008, 82, 2120–2129. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 2120-2129
-
-
Gastaminza, P.1
Cheng, G.2
Wieland, S.3
Zhong, J.4
Liao, W.5
Chisari, F.V.6
-
243
-
-
34250337631
-
Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins
-
[CrossRef] [PubMed]
-
Huang, H.; Sun, F.; Owen, D.M.; Li, W.; Chen, Y.; Gale, M., Jr.; Ye, J. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. USA 2007, 104, 5848–5853. [CrossRef] [PubMed]
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 5848-5853
-
-
Huang, H.1
Sun, F.2
Owen, D.M.3
Li, W.4
Chen, Y.5
Gale, M.6
Ye, J.7
-
244
-
-
72849106317
-
Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles
-
[CrossRef] [PubMed]
-
Jiang, J.; Luo, G. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J. Virol. 2009, 83, 12680–12691. [CrossRef] [PubMed]
-
(2009)
J. Virol
, vol.83
, pp. 12680-12691
-
-
Jiang, J.1
Luo, G.2
-
245
-
-
84869025358
-
Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells
-
[CrossRef] [PubMed]
-
Da Costa, D.; Turek, M.; Felmlee, D.J.; Girardi, E.; Pfeffer, S.; Long, G.; Bartenschlager, R.; Zeisel, M.B.; Baumert, T.F. Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells. J. Virol. 2012, 86, 11919–11925. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 11919-11925
-
-
Da Costa, D.1
Turek, M.2
Felmlee, D.J.3
Girardi, E.4
Pfeffer, S.5
Long, G.6
Bartenschlager, R.7
Zeisel, M.B.8
Baumert, T.F.9
-
246
-
-
84919629164
-
Amphipathic alpha-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles
-
[CrossRef] [PubMed]
-
Fukuhara, T.; Wada, M.; Nakamura, S.; Ono, C.; Shiokawa, M.; Yamamoto, S.; Motomura, T.; Okamoto, T.; Okuzaki, D.; Yamamoto, M., et al. Amphipathic alpha-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles. PLoS Pathog. 2014, 10, e1004534. [CrossRef] [PubMed]
-
(2014)
Plos Pathog
, vol.10
-
-
Fukuhara, T.1
Wada, M.2
Nakamura, S.3
Ono, C.4
Shiokawa, M.5
Yamamoto, S.6
Motomura, T.7
Okamoto, T.8
Okuzaki, D.9
Yamamoto, M.10
-
247
-
-
79959897198
-
Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entry
-
[CrossRef] [PubMed]
-
Maurin, G.; Fresquet, J.; Granio, O.; Wychowski, C.; Cosset, F.L.; Lavillette, D. Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entry. J. Biol. Chem. 2011, 286, 23865–23876. [CrossRef] [PubMed]
-
(2011)
J. Biol. Chem
, vol.286
, pp. 23865-23876
-
-
Maurin, G.1
Fresquet, J.2
Granio, O.3
Wychowski, C.4
Cosset, F.L.5
Lavillette, D.6
-
248
-
-
84873040161
-
Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry
-
[CrossRef] [PubMed]
-
Carlsen, T.H.; Scheel, T.K.; Ramirez, S.; Foung, S.K.; Bukh, J. Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry. J. Virol. 2013, 87, 1385–1399. [CrossRef] [PubMed]
-
(2013)
J. Virol
, vol.87
, pp. 1385-1399
-
-
Carlsen, T.H.1
Scheel, T.K.2
Ramirez, S.3
Foung, S.K.4
Bukh, J.5
-
249
-
-
84888057318
-
Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopment
-
[CrossRef] [PubMed]
-
Steinmann, E.; Doerrbecker, J.; Friesland, M.; Riebesehl, N.; Ginkel, C.; Hillung, J.; Gentzsch, J.; Lauber, C.; Brown, R.; Frentzen, A., et al. Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopment. J. Virol. 2013, 87, 13297–13306. [CrossRef] [PubMed]
-
(2013)
J. Virol
, vol.87
, pp. 13297-13306
-
-
Steinmann, E.1
Doerrbecker, J.2
Friesland, M.3
Riebesehl, N.4
Ginkel, C.5
Hillung, J.6
Gentzsch, J.7
Lauber, C.8
Brown, R.9
Frentzen, A.10
-
250
-
-
84873083416
-
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
-
[CrossRef] [PubMed]
-
Prokunina-Olsson, L.; Muchmore, B.; Tang, W.; Pfeiffer, R.M.; Park, H.; Dickensheets, H.; Hergott, D.; Porter-Gill, P.; Mumy, A.; Kohaar, I., et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat. Genet. 2013, 45, 164–171. [CrossRef] [PubMed]
-
(2013)
Nat. Genet
, vol.45
, pp. 164-171
-
-
Prokunina-Olsson, L.1
Muchmore, B.2
Tang, W.3
Pfeiffer, R.M.4
Park, H.5
Dickensheets, H.6
Hergott, D.7
Porter-Gill, P.8
Mumy, A.9
Kohaar, I.10
-
251
-
-
84873813418
-
Loss of function of the new interferon IFN-lambda4 may confer protection from hepatitis C
-
[CrossRef] [PubMed]
-
Booth, D.; George, J. Loss of function of the new interferon IFN-lambda4 may confer protection from hepatitis C. Nat. Genet. 2013, 45, 119–120. [CrossRef] [PubMed]
-
(2013)
Nat. Genet
, vol.45
, pp. 119-120
-
-
Booth, D.1
George, J.2
-
252
-
-
84911947163
-
Type I interferon rapidly restricts infectious hepatitis C virus particle genesis
-
[CrossRef] [PubMed]
-
Meredith, L.W.; Farquhar, M.J.; Tarr, A.W.; McKeating, J.A. Type I interferon rapidly restricts infectious hepatitis C virus particle genesis. Hepatology 2014, 60, 1891–1901. [CrossRef] [PubMed]
-
(2014)
Hepatology
, vol.60
, pp. 1891-1901
-
-
Meredith, L.W.1
Farquhar, M.J.2
Tarr, A.W.3
McKeating, J.A.4
-
253
-
-
79955542915
-
A diverse range of gene products are effectors of the type I interferon antiviral response
-
[CrossRef] [PubMed]
-
Schoggins, J.W.; Wilson, S.J.; Panis, M.; Murphy, M.Y.; Jones, C.T.; Bieniasz, P.; Rice, C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472, 481–485. [CrossRef] [PubMed]
-
(2011)
Nature
, vol.472
, pp. 481-485
-
-
Schoggins, J.W.1
Wilson, S.J.2
Panis, M.3
Murphy, M.Y.4
Jones, C.T.5
Bieniasz, P.6
Rice, C.M.7
-
254
-
-
0036133193
-
Virus evolutionary patterns studied through analysis of full-genome sequences
-
[CrossRef] [PubMed]
-
Salemi, M.; Vandamme, A.M. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J. Mol. Evol. 2002, 54, 62–70. [CrossRef] [PubMed]
-
(2002)
J. Mol. Evol
, vol.54
, pp. 62-70
-
-
Salemi, M.1
Vandamme, A.M.2
Hepatitis, C.3
-
255
-
-
84886850346
-
Viral evolution explains the associations among hepatitis C virus genotype, clinical outcomes, and human genetic variation
-
[CrossRef] [PubMed]
-
Rose, R.; Markov, P.V.; Lam, T.T.; Pybus, O.G. Viral evolution explains the associations among hepatitis C virus genotype, clinical outcomes, and human genetic variation. Infect. Genet. Evol. 2013, 20, 418–421. [CrossRef] [PubMed]
-
(2013)
Infect. Genet. Evol
, vol.20
, pp. 418-421
-
-
Rose, R.1
Markov, P.V.2
Lam, T.T.3
Pybus, O.G.4
-
256
-
-
0033516497
-
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
-
[CrossRef] [PubMed]
-
Taylor, D.R.; Shi, S.T.; Romano, P.R.; Barber, G.N.; Lai, M.M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999, 285, 107–110. [CrossRef] [PubMed]
-
(1999)
Science
, vol.285
, pp. 107-110
-
-
Taylor, D.R.1
Shi, S.T.2
Romano, P.R.3
Barber, G.N.4
Lai, M.M.5
-
257
-
-
0035148472
-
Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain
-
[CrossRef] [PubMed]
-
Taylor, D.R.; Tian, B.; Romano, P.R.; Hinnebusch, A.G.; Lai, M.M.; Mathews, M.B. Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain. J. Virol. 2001, 75, 1265–1273. [CrossRef] [PubMed]
-
(2001)
J. Virol
, vol.75
, pp. 1265-1273
-
-
Taylor, D.R.1
Tian, B.2
Romano, P.R.3
Hinnebusch, A.G.4
Lai, M.M.5
Mathews, M.B.6
-
258
-
-
78650634419
-
Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients
-
[CrossRef] [PubMed]
-
Afzal, S.; Idrees, M.; Akram, M.; Awan, Z.; Khubaib, B.; Aftab, M.; Fatima, Z.; Badar, S.; Hussain, A. Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients. Virol. J. 2010, 7, e377. [CrossRef] [PubMed]
-
(2010)
Virol. J
, vol.7
-
-
Afzal, S.1
Idrees, M.2
Akram, M.3
Awan, Z.4
Khubaib, B.5
Aftab, M.6
Fatima, Z.7
Badar, S.8
Hussain, A.9
-
259
-
-
45749153381
-
Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses
-
[CrossRef] [PubMed]
-
Munoz de Rueda, P.; Casado, J.; Paton, R.; Quintero, D.; Palacios, A.; Gila, A.; Quiles, R.; Leon, J.; Ruiz-Extremera, A.; Salmeron, J. Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses. J. Virol. 2008, 82, 6644–6653. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 6644-6653
-
-
De Munoz Rueda, P.1
Casado, J.2
Paton, R.3
Quintero, D.4
Palacios, A.5
Gila, A.6
Quiles, R.7
Leon, J.8
Ruiz-Extremera, A.9
Salmeron, J.10
-
260
-
-
33745451836
-
Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: Their correlation with response to interferon monotherapy and viral load
-
[PubMed]
-
Ukai, K.; Ishigami, M.; Yoshioka, K.; Kawabe, N.; Katano, Y.; Hayashi, K.; Honda, T.; Yano, M.; Goto, H. Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: Their correlation with response to interferon monotherapy and viral load. World J. Gastroenterol. 2006, 12, 3722–3728. [PubMed]
-
(2006)
World J. Gastroenterol
, vol.12
, pp. 3722-3728
-
-
Ukai, K.1
Ishigami, M.2
Yoshioka, K.3
Kawabe, N.4
Katano, Y.5
Hayashi, K.6
Honda, T.7
Yano, M.8
Goto, H.9
-
261
-
-
0033837013
-
The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon
-
[CrossRef] [PubMed]
-
Polyak, S.J.; Nousbaum, J.B.; Larson, A.M.; Cotler, S.; Carithers, R.L., Jr.; Gretch, D.R. The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon. J. Infect. Dis. 2000, 182, 397–404. [CrossRef] [PubMed]
-
(2000)
J. Infect. Dis
, vol.182
, pp. 397-404
-
-
Polyak, S.J.1
Nousbaum, J.B.2
Larson, A.M.3
Cotler, S.4
Carithers, R.L.5
Gretch, D.R.6
-
262
-
-
0033653568
-
Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment
-
[CrossRef] [PubMed]
-
Berg, T.; Mas Marques, A.; Hohne, M.; Wiedenmann, B.; Hopf, U.; Schreier, E. Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment. Hepatology 2000, 32, 1386–1395. [CrossRef] [PubMed]
-
(2000)
Hepatology
, vol.32
, pp. 1386-1395
-
-
Berg, T.1
Mas Marques, A.2
Hohne, M.3
Wiedenmann, B.4
Hopf, U.5
Schreier, E.6
-
263
-
-
84887158912
-
Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance
-
[CrossRef] [PubMed]
-
Serre, S.B.; Krarup, H.B.; Bukh, J.; Gottwein, J.M. Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance. J. Virol. 2013, 87, 12776–12793. [CrossRef] [PubMed]
-
(2013)
J. Virol
, vol.87
, pp. 12776-12793
-
-
Serre, S.B.1
Krarup, H.B.2
Bukh, J.3
Gottwein, J.M.4
-
264
-
-
84880353282
-
Response of hepatitis C virus to long-term passage in the presence of alpha interferon: Multiple mutations and a common phenotype
-
[CrossRef] [PubMed]
-
Perales, C.; Beach, N.M.; Gallego, I.; Soria, M.E.; Quer, J.; Esteban, J.I.; Rice, C.; Domingo, E.; Sheldon, J. Response of hepatitis C virus to long-term passage in the presence of alpha interferon: Multiple mutations and a common phenotype. J. Virol. 2013, 87, 7593–7607. [CrossRef] [PubMed]
-
(2013)
J. Virol
, vol.87
, pp. 7593-7607
-
-
Perales, C.1
Beach, N.M.2
Gallego, I.3
Soria, M.E.4
Quer, J.5
Esteban, J.I.6
Rice, C.7
Domingo, E.8
Sheldon, J.9
-
265
-
-
84907913102
-
Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus
-
[CrossRef] [PubMed]
-
Sheldon, J.; Beach, N.M.; Moreno, E.; Gallego, I.; Pineiro, D.; Martinez-Salas, E.; Gregori, J.; Quer, J.; Esteban, J.I.; Rice, C.M., et al. Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus. J. Virol. 2014, 88, 12098–12111. [CrossRef] [PubMed]
-
(2014)
J. Virol
, vol.88
, pp. 12098-12111
-
-
Sheldon, J.1
Beach, N.M.2
Moreno, E.3
Gallego, I.4
Pineiro, D.5
Martinez-Salas, E.6
Gregori, J.7
Quer, J.8
Esteban, J.I.9
Rice, C.M.10
-
266
-
-
84862579286
-
Viral quasispecies evolution
-
[CrossRef] [PubMed]
-
Domingo, E.; Sheldon, J.; Perales, C. Viral quasispecies evolution. Microbiol. Mol. Biol. Rev. 2012, 76, 159–216. [CrossRef] [PubMed]
-
(2012)
Microbiol. Mol. Biol. Rev
, vol.76
, pp. 159-216
-
-
Domingo, E.1
Sheldon, J.2
Perales, C.3
-
267
-
-
84870533821
-
HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells
-
[CrossRef] [PubMed]
-
Florentin, J.; Aouar, B.; Dental, C.; Thumann, C.; Firaguay, G.; Gondois-Rey, F.; Soumelis, V.; Baumert, T.F.; Nunes, J.A.; Olive, D., et al. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. Blood 2012, 120, 4544–4551. [CrossRef] [PubMed]
-
(2012)
Blood
, vol.120
, pp. 4544-4551
-
-
Florentin, J.1
Aouar, B.2
Dental, C.3
Thumann, C.4
Firaguay, G.5
Gondois-Rey, F.6
Soumelis, V.7
Baumert, T.F.8
Nunes, J.A.9
Olive, D.10
-
268
-
-
84863774072
-
Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses
-
[CrossRef] [PubMed]
-
Burton, D.R.; Poignard, P.; Stanfield, R.L.; Wilson, I.A. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 2012, 337, 183–186. [CrossRef] [PubMed]
-
(2012)
Science
, vol.337
, pp. 183-186
-
-
Burton, D.R.1
Poignard, P.2
Stanfield, R.L.3
Wilson, I.A.4
-
269
-
-
84875551472
-
Broadly neutralizing antiviral antibodies
-
[CrossRef] [PubMed]
-
Corti, D.; Lanzavecchia, A. Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. 2013, 31, 705–742. [CrossRef] [PubMed]
-
(2013)
Annu. Rev. Immunol
, vol.31
, pp. 705-742
-
-
Corti, D.1
Lanzavecchia, A.2
-
270
-
-
33846243704
-
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: Evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease
-
[CrossRef] [PubMed]
-
Lake-Bakaar, G.; Dustin, L.; McKeating, J.; Newton, K.; Freeman, V.; Frost, S.D. Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: Evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease. Blood 2007, 109, 845–846. [CrossRef] [PubMed]
-
(2007)
Blood
, vol.109
, pp. 845-846
-
-
Lake-Bakaar, G.1
Dustin, L.2
McKeating, J.3
Newton, K.4
Freeman, V.5
Frost, S.D.6
-
271
-
-
77955915180
-
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease
-
[CrossRef] [PubMed]
-
Petrarca, A.; Rigacci, L.; Caini, P.; Colagrande, S.; Romagnoli, P.; Vizzutti, F.; Arena, U.; Giannini, C.; Monti, M.; Montalto, P., et al. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease. Blood 2010, 116, 335–342. [CrossRef] [PubMed]
-
(2010)
Blood
, vol.116
, pp. 335-342
-
-
Petrarca, A.1
Rigacci, L.2
Caini, P.3
Colagrande, S.4
Romagnoli, P.5
Vizzutti, F.6
Arena, U.7
Giannini, C.8
Monti, M.9
Montalto, P.10
-
272
-
-
84863183220
-
Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion
-
[CrossRef] [PubMed]
-
Raghuraman, S.; Park, H.; Osburn, W.O.; Winkelstein, E.; Edlin, B.R.; Rehermann, B. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J. Infect. Dis. 2012, 205, 763–771. [CrossRef] [PubMed]
-
(2012)
J. Infect. Dis
, vol.205
, pp. 763-771
-
-
Raghuraman, S.1
Park, H.2
Osburn, W.O.3
Winkelstein, E.4
Edlin, B.R.5
Rehermann, B.6
-
273
-
-
70450162452
-
Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus
-
[CrossRef] [PubMed]
-
Broering, T.J.; Garrity, K.A.; Boatright, N.K.; Sloan, S.E.; Sandor, F.; Thomas, W.D., Jr.; Szabo, G.; Finberg, R.W.; Ambrosino, D.M.; Babcock, G.J. Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. J. Virol. 2009, 83, 12473–12482. [CrossRef] [PubMed]
-
(2009)
J. Virol
, vol.83
, pp. 12473-12482
-
-
Broering, T.J.1
Garrity, K.A.2
Boatright, N.K.3
Sloan, S.E.4
Sandor, F.5
Thomas, W.D.6
Szabo, G.7
Finberg, R.W.8
Ambrosino, D.M.9
Babcock, G.J.10
-
274
-
-
0344630279
-
In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes
-
[CrossRef] [PubMed]
-
Bartosch, B.; Bukh, J.; Meunier, J.C.; Granier, C.; Engle, R.E.; Blackwelder, W.C.; Emerson, S.U.; Cosset, F.L.; Purcell, R.H. In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes. Proc. Natl. Acad. Sci. USA 2003, 100, 14199–14204. [CrossRef] [PubMed]
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 14199-14204
-
-
Bartosch, B.1
Bukh, J.2
Meunier, J.C.3
Granier, C.4
Engle, R.E.5
Blackwelder, W.C.6
Emerson, S.U.7
Cosset, F.L.8
Purcell, R.H.9
-
275
-
-
84878472445
-
Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape
-
[CrossRef] [PubMed]
-
Krey, T.; Meola, A.; Keck, Z.Y.; Damier-Piolle, L.; Foung, S.K.; Rey, F.A. Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape. PLoS Pathog. 2013, 9, e1003364. [CrossRef] [PubMed]
-
(2013)
Plos Pathog
, vol.9
-
-
Krey, T.1
Meola, A.2
Keck, Z.Y.3
Damier-Piolle, L.4
Foung, S.K.5
Rey, F.A.6
-
276
-
-
44949239692
-
A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope
-
[CrossRef] [PubMed]
-
Keck, Z.Y.; Olson, O.; Gal-Tanamy, M.; Xia, J.; Patel, A.H.; Dreux, M.; Cosset, F.L.; Lemon, S.M.; Foung, S.K. A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope. J. Virol. 2008, 82, 6067–6072. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 6067-6072
-
-
Keck, Z.Y.1
Olson, O.2
Gal-Tanamy, M.3
Xia, J.4
Patel, A.H.5
Dreux, M.6
Cosset, F.L.7
Lemon, S.M.8
Foung, S.K.9
-
277
-
-
66149117798
-
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity
-
[CrossRef] [PubMed]
-
Keck, Z.Y.; Li, S.H.; Xia, J.; von Hahn, T.; Balfe, P.; McKeating, J.A.; Witteveldt, J.; Patel, A.H.; Alter, H.; Rice, C.M., et al. Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity. J. Virol. 2009, 83, 6149–6160. [CrossRef] [PubMed]
-
(2009)
J. Virol
, vol.83
, pp. 6149-6160
-
-
Keck, Z.Y.1
Li, S.H.2
Xia, J.3
Von Hahn, T.4
Balfe, P.5
McKeating, J.A.6
Witteveldt, J.7
Patel, A.H.8
Alter, H.9
Rice, C.M.10
-
278
-
-
84866152584
-
Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees
-
[CrossRef] [PubMed]
-
Morin, T.J.; Broering, T.J.; Leav, B.A.; Blair, B.M.; Rowley, K.J.; Boucher, E.N.; Wang, Y.; Cheslock, P.S.; Knauber, M.; Olsen, D.B., et al. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. PLoS Pathog. 2012, 8, e1002895. [CrossRef] [PubMed]
-
(2012)
Plos Pathog
, vol.8
-
-
Morin, T.J.1
Broering, T.J.2
Leav, B.A.3
Blair, B.M.4
Rowley, K.J.5
Boucher, E.N.6
Wang, Y.7
Cheslock, P.S.8
Knauber, M.9
Olsen, D.B.10
-
279
-
-
0028087985
-
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization
-
[CrossRef] [PubMed]
-
Farci, P.; Alter, H.J.; Wong, D.C.; Miller, R.H.; Govindarajan, S.; Engle, R.; Shapiro, M.; Purcell, R.H. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 1994, 91, 7792–7796. [CrossRef] [PubMed]
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 7792-7796
-
-
Farci, P.1
Alter, H.J.2
Wong, D.C.3
Miller, R.H.4
Govindarajan, S.5
Engle, R.6
Shapiro, M.7
Purcell, R.H.8
-
280
-
-
84907291992
-
Broadly neutralizing antibodies abrogateestablished hepatitis C virus infection
-
De Jong, Y.P.; Dorner, M.; Mommersteeg, M.C.; Xiao, J.W.; Balazs, A.B.; Robbins, J.B.; Winer, B.Y.; Gerges, S.; Vega, K.; Labitt, R.N., et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci. Transl. Med. 2014, 6.
-
(2014)
Sci. Transl. Med
-
-
De Jong, Y.P.1
Dorner, M.2
Mommersteeg, M.C.3
Xiao, J.W.4
Balazs, A.B.5
Robbins, J.B.6
Winer, B.Y.7
Gerges, S.8
Vega, K.9
Labitt, R.N.10
-
281
-
-
84937495420
-
-
[CrossRef] [PubMed]
-
254ra129. [CrossRef] [PubMed]
-
-
-
-
282
-
-
0028147612
-
Vaccination of chimpanzees against infection by the hepatitis C virus
-
[CrossRef] [PubMed]
-
Choo, Q.L.; Kuo, G.; Ralston, R.; Weiner, A.; Chien, D.; van Nest, G.; Han, J.; Berger, K.; Thudium, K.; Kuo, C. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 1994, 91, 1294–1298. [CrossRef] [PubMed]
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 1294-1298
-
-
Choo, Q.L.1
Kuo, G.2
Ralston, R.3
Weiner, A.4
Chien, D.5
Van Nest, G.6
Han, J.7
Berger, K.8
Thudium, K.9
Kuo, C.10
-
283
-
-
23944452579
-
Prospects for a vaccine against the hepatitis C virus
-
[CrossRef] [PubMed]
-
Houghton, M.; Abrignani, S. Prospects for a vaccine against the hepatitis C virus. Nature 2005, 436, 961–966. [CrossRef] [PubMed]
-
(2005)
Nature
, vol.436
, pp. 961-966
-
-
Houghton, M.1
Abrignani, S.2
-
284
-
-
78650536657
-
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
-
[CrossRef] [PubMed]
-
Houghton, M. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses. Immunol. Rev. 2011, 239, 99–108. [CrossRef] [PubMed]
-
(2011)
Immunol. Rev
, vol.239
, pp. 99-108
-
-
Houghton, M.1
-
285
-
-
80052894158
-
Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus
-
[CrossRef] [PubMed]
-
Meunier, J.C.; Gottwein, J.M.; Houghton, M.; Russell, R.S.; Emerson, S.U.; Bukh, J.; Purcell, R.H. Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus. J. Infect. Dis. 2011, 204, 1186–1190. [CrossRef] [PubMed]
-
(2011)
J. Infect. Dis
, vol.204
, pp. 1186-1190
-
-
Meunier, J.C.1
Gottwein, J.M.2
Houghton, M.3
Russell, R.S.4
Emerson, S.U.5
Bukh, J.6
Purcell, R.H.7
-
286
-
-
77955661037
-
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
-
[CrossRef] [PubMed]
-
Frey, S.E.; Houghton, M.; Coates, S.; Abrignani, S.; Chien, D.; Rosa, D.; Pileri, P.; Ray, R.; di Bisceglie, A.M.; Rinella, P., et al. Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. Vaccine 2010, 28, 6367–6373. [CrossRef] [PubMed]
-
(2010)
Vaccine
, vol.28
, pp. 6367-6373
-
-
Frey, S.E.1
Houghton, M.2
Coates, S.3
Abrignani, S.4
Chien, D.5
Rosa, D.6
Pileri, P.7
Ray, R.8
Di Bisceglie, A.M.9
Rinella, P.10
-
287
-
-
84875122982
-
A Hepatitis C Virus (HCV) vaccine comprising envelope glycoproteins gpe1/gpe2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans
-
[CrossRef] [PubMed]
-
Law, J.L.M.; Chen, C.; Wong, J.; Hockman, D.; Santer, D.M.; Frey, S.E.; Belshe, R.B.; Wakita, T.; Bukh, J.; Jones, C.T., et al. A Hepatitis C Virus (HCV) vaccine comprising envelope glycoproteins gpe1/gpe2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. PLoS ONE 2013, 8, e59776. [CrossRef] [PubMed]
-
(2013)
Plos ONE
, vol.8
-
-
Law, J.1
Chen, C.2
Wong, J.3
Hockman, D.4
Santer, D.M.5
Frey, S.E.6
Belshe, R.B.7
Wakita, T.8
Bukh, J.9
Jones, C.T.10
-
288
-
-
85042750982
-
Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy
-
[CrossRef] [PubMed]
-
El-Awady, M.K.; El Gendy, M.; Waked, I.; Tabll, A.A.; El Abd, Y.; Bader El Din, N.; El Shenawy, R.; Allam, A.; Abdelhafez, T.H.; Dawood, R.M. Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy. Vaccine 2013. [CrossRef] [PubMed]
-
(2013)
Vaccine
-
-
El-Awady, M.K.1
El Gendy, M.2
Waked, I.3
Tabll, A.A.4
El Abd, Y.5
El Bader Din, N.6
El Shenawy, R.7
Allam, A.8
Abdelhafez, T.H.9
Dawood, R.M.10
-
289
-
-
84880575939
-
Neutralizing antibodies induced by cell culture–derived hepatitis c virus protect against infection in mice
-
[CrossRef] [PubMed]
-
Akazawa, D.; Moriyama, M.; Yokokawa, H.; Omi, N.; Watanabe, N.; Date, T.; Morikawa, K.; Aizaki, H.; Ishii, K.; Kato, T., et al. Neutralizing antibodies induced by cell culture–derived hepatitis c virus protect against infection in mice. Gastroenterology 2013, 145, 447–455.e4. [CrossRef] [PubMed]
-
(2013)
Gastroenterology
, vol.145
, pp. 447-455
-
-
Akazawa, D.1
Moriyama, M.2
Yokokawa, H.3
Omi, N.4
Watanabe, N.5
Date, T.6
Morikawa, K.7
Aizaki, H.8
Ishii, K.9
Kato, T.10
-
290
-
-
0030914741
-
Plasmid DNA-based immunization for hepatitis C virus structural proteins: Immune responses in mice
-
[CrossRef]
-
Saito, T.; Sherman, G.J.; Kurokohchi, K.; Guo, Z.P.; Donets, M.; Yu, M.Y.; Berzofsky, J.A.; Akatsuka, T.; Feinstone, S.M. Plasmid DNA-based immunization for hepatitis C virus structural proteins: Immune responses in mice. Gastroenterology 1997, 112, 1321–1330. [CrossRef]
-
(1997)
Gastroenterology
, vol.112
, pp. 1321-1330
-
-
Saito, T.1
Sherman, G.J.2
Kurokohchi, K.3
Guo, Z.P.4
Donets, M.5
Yu, M.Y.6
Berzofsky, J.A.7
Akatsuka, T.8
Feinstone, S.M.9
-
291
-
-
0033848911
-
Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV
-
[CrossRef] [PubMed]
-
Forns, X.; ayette, P.J.; Ma, X.; Satterfield, W.; Eder, G.; Mushahwar, I.K.; Govindarajan, S.; Davis, H.L.; Emerson, S.U.; Purcell, R.H., et al. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology 2000, 32, 618–625. [CrossRef] [PubMed]
-
(2000)
Hepatology
, vol.32
, pp. 618-625
-
-
Forns, X.1
Ayette, P.J.2
Ma, X.3
Satterfield, W.4
Eder, G.5
Mushahwar, I.K.6
Govindarajan, S.7
Davis, H.L.8
Emerson, S.U.9
Purcell, R.H.10
-
292
-
-
60349132278
-
Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial
-
[CrossRef] [PubMed]
-
Alvarez-Lajonchere, L.; Shoukry, N.H.; Grá, B.; Amador-Cañizares, Y.; Helle, F.; Bédard, N.; Guerra, I.; Drouin, C.; Dubuisson, J.; González-Horta, E.E., et al. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial. J. Viral Hepat. 2009, 16, 156–167. [CrossRef] [PubMed]
-
(2009)
J. Viral Hepat
, vol.16
, pp. 156-167
-
-
Alvarez-Lajonchere, L.1
Shoukry, N.H.2
Grá, B.3
Amador-Cañizares, Y.4
Helle, F.5
Bédard, N.6
Guerra, I.7
Drouin, C.8
Dubuisson, J.9
González-Horta, E.E.10
-
293
-
-
70349542749
-
Advances in DNA immunization against hepatitis C virus infection
-
[CrossRef]
-
Alvarez-Lajonchere, L.; Dueñas-Carrera, S. Advances in DNA immunization against hepatitis C virus infection. Hum. Vaccines 2009, 5, 568–571. [CrossRef]
-
(2009)
Hum. Vaccines
, vol.5
, pp. 568-571
-
-
Alvarez-Lajonchere, L.1
Dueñas-Carrera, S.2
-
294
-
-
34247846212
-
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization
-
[CrossRef] [PubMed]
-
Denis, J.; Majeau, N.; Acosta-Ramirez, E.; Savard, C.; Bedard, M.-C.; Simard, S.; Lecours, K.; Bolduc, M.; Pare, C.; Willems, B., et al. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization. Virology 2007, 363, 59–68. [CrossRef] [PubMed]
-
(2007)
Virology
, vol.363
, pp. 59-68
-
-
Denis, J.1
Majeau, N.2
Acosta-Ramirez, E.3
Savard, C.4
Bedard, M.-C.5
Simard, S.6
Lecours, K.7
Bolduc, M.8
Pare, C.9
Willems, B.10
-
295
-
-
66149161654
-
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (Types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: A randomised, double-blind trial
-
[CrossRef]
-
Muñoz, N.; Manalastas, R.; Pitisuttithum, P.; Tresukosol, D.; Monsonego, J.; Ault, K.; Clavel, C.; Luna, J.; Myers, E.; Hood, S., et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: A randomised, double-blind trial. Lancet 2009, 373, 1949–1957. [CrossRef]
-
(2009)
Lancet
, vol.373
, pp. 1949-1957
-
-
Muñoz, N.1
Manalastas, R.2
Pitisuttithum, P.3
Tresukosol, D.4
Monsonego, J.5
Ault, K.6
Clavel, C.7
Luna, J.8
Myers, E.9
Hood, S.10
-
296
-
-
0021238117
-
Human hepatitis B vaccine from recombinant yeast
-
[CrossRef] [PubMed]
-
McAleer, W.J.; Buynak, E.B.; Maigetter, R.Z.; Wampler, D.E.; Miller, W.J.; Hilleman, M.R. Human hepatitis B vaccine from recombinant yeast. Nature 1984, 307, 178–180. [CrossRef] [PubMed]
-
(1984)
Nature
, vol.307
, pp. 178-180
-
-
McAleer, W.J.1
Buynak, E.B.2
Maigetter, R.Z.3
Wampler, D.E.4
Miller, W.J.5
Hilleman, M.R.6
-
297
-
-
0031977996
-
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells
-
[PubMed]
-
Baumert, T.F.; Ito, S.; Wong, D.T.; Liang, T.J. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J. Virol. 1998, 72, 3827–3836. [PubMed]
-
(1998)
J. Virol
, vol.72
, pp. 3827-3836
-
-
Baumert, T.F.1
Ito, S.2
Wong, D.T.3
Liang, T.J.4
-
298
-
-
4444335280
-
Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity
-
[PubMed]
-
Zhao, W.; Liao, G.-Y.; Jiang, Y.-J.; Jiang, S.-D. Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity. Chin. Med. J. 2004, 117, 1217–1222. [PubMed]
-
(2004)
Chin. Med. J
, vol.117
, pp. 1217-1222
-
-
Zhao, W.1
Liao, G.-Y.2
Jiang, Y.-J.3
Jiang, S.-D.4
-
299
-
-
34347213785
-
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees
-
[CrossRef] [PubMed]
-
Elmowalid, G.A.; Qiao, M.; Jeong, S.-H.; Borg, B.B.; Baumert, T.F.; Sapp, R.K.; Hu, Z.; Murthy, K.; Liang, T.J. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc. Natl. Acad. Sci. USA 2007, 104, 8427–8432. [CrossRef] [PubMed]
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 8427-8432
-
-
Elmowalid, G.A.1
Qiao, M.2
Jeong, S.-H.3
Borg, B.B.4
Baumert, T.F.5
Sapp, R.K.6
Hu, Z.7
Murthy, K.8
Liang, T.J.9
-
300
-
-
2942643933
-
Immunization with hepatitis c virus-like particles induces humoral and cellular immune responses in nonhuman primates
-
[CrossRef] [PubMed]
-
Jeong, S.-H.; Qiao, M.; Nascimbeni, M.; Hu, Z.; Rehermann, B.; Murthy, K.; Liang, T.J. Immunization with hepatitis c virus-like particles induces humoral and cellular immune responses in nonhuman primates. J. Virol. 2004, 78, 6995–7003. [CrossRef] [PubMed]
-
(2004)
J. Virol
, vol.78
, pp. 6995-7003
-
-
Jeong, S.-H.1
Qiao, M.2
Nascimbeni, M.3
Hu, Z.4
Rehermann, B.5
Murthy, K.6
Liang, T.J.7
-
301
-
-
0037219273
-
Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses
-
[CrossRef] [PubMed]
-
Qiao, M.; Murata, K.; Davis, A.R.; Jeong, S.-H.; Liang, T.J. Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses. Hepatology 2003, 37, 52–59. [CrossRef] [PubMed]
-
(2003)
Hepatology
, vol.37
, pp. 52-59
-
-
Qiao, M.1
Murata, K.2
Davis, A.R.3
Jeong, S.-H.4
Liang, T.J.5
-
302
-
-
84874444963
-
Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice
-
[CrossRef] [PubMed]
-
Huret, C.; Desjardins, D.; Miyalou, M.; Levacher, B.; Amadoudji Zin, M.; Bonduelle, O.; Combadière, B.; Dalba, C.; Klatzmann, D.; Bellier, B. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Vaccine 2013, 31, 1540–1547. [CrossRef] [PubMed]
-
(2013)
Vaccine
, vol.31
, pp. 1540-1547
-
-
Huret, C.1
Desjardins, D.2
Miyalou, M.3
Levacher, B.4
Amadoudji Zin, M.5
Bonduelle, O.6
Combadière, B.7
Dalba, C.8
Klatzmann, D.9
Bellier, B.10
-
303
-
-
84876114944
-
Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine
-
[CrossRef] [PubMed]
-
Beaumont, E.; Patient, R.; Hourioux, C.; Dimier-Poisson, I.; Roingeard, P. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine. Hepatology 2013, 57, 1303–1313. [CrossRef] [PubMed]
-
(2013)
Hepatology
, vol.57
, pp. 1303-1313
-
-
Beaumont, E.1
Patient, R.2
Hourioux, C.3
Dimier-Poisson, I.4
Roingeard, P.5
-
304
-
-
79961221361
-
A prime-boost strategy using virus-like particles pseudotyped for hcv proteins triggers broadly neutralizing antibodies in macaques
-
Garrone, P.; Fluckiger, A.-C.; Mangeot, P.E.; Gauthier, E.; Dupeyrot-Lacas, P.; Mancip, J.; Cangialosi, A.; Du Chene, I.; LeGrand, R.; Mangeot, I., et al. A prime-boost strategy using virus-like particles pseudotyped for hcv proteins triggers broadly neutralizing antibodies in macaques. Sci. Transl. Med. 2011, 3.
-
(2011)
Sci. Transl. Med
-
-
Garrone, P.1
Fluckiger, A.-C.2
Mangeot, P.E.3
Gauthier, E.4
Dupeyrot-Lacas, P.5
Mancip, J.6
Cangialosi, A.7
Du Chene, I.8
Legrand, R.9
Mangeot, I.10
-
305
-
-
84937495421
-
-
[CrossRef] [PubMed]
-
94ra71. [CrossRef] [PubMed]
-
-
-
-
306
-
-
84875931857
-
Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets
-
[CrossRef] [PubMed]
-
De Cassan, S.C.; Draper, S.J. Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets. Expert Rev. Vaccines 2013, 12, 365–378. [CrossRef] [PubMed]
-
(2013)
Expert Rev. Vaccines
, vol.12
, pp. 365-378
-
-
De Cassan, S.C.1
Draper, S.J.2
-
307
-
-
47749130475
-
Induction of broad CD4+ and CD8+ T-cell responses and cross- neutralizing antibodies against hepatitis C virus by vaccination with th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and N
-
[CrossRef] [PubMed]
-
Lin, Y.; Kwon, T.; Polo, J.; Zhu, Y.-F.; Coates, S.; Crawford, K.; Dong, C.; Wininger, M.; Hall, J.; Selby, M., et al. Induction of broad CD4+ and CD8+ T-cell responses and cross- neutralizing antibodies against hepatitis C virus by vaccination with th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and N. J. Virol. 2008, 82, 7492–7503. [CrossRef] [PubMed]
-
(2008)
J. Virol
, vol.82
, pp. 7492-7503
-
-
Lin, Y.1
Kwon, T.2
Polo, J.3
Zhu, Y.-F.4
Coates, S.5
Crawford, K.6
Dong, C.7
Wininger, M.8
Hall, J.9
Selby, M.10
-
308
-
-
84869061330
-
Broadly neutralizing immune responses against hepatitis c virus induced by vectored measles viruses and a recombinant envelope protein booster
-
[CrossRef] [PubMed]
-
Reyes-del Valle, J.; de la Fuente, C.; Turner, M.A.; Springfeld, C.; Apte-Sengupta, S.; Frenzke, M.E.; Forest, A.; Whidby, J.; Marcotrigiano, J.; Rice, C.M., et al. Broadly neutralizing immune responses against hepatitis c virus induced by vectored measles viruses and a recombinant envelope protein booster. J. Virol. 2012, 86, 11558–11566. [CrossRef] [PubMed]
-
(2012)
J. Virol
, vol.86
, pp. 11558-11566
-
-
Reyes-Del Valle, J.1
De La Fuente, C.2
Turner, M.A.3
Springfeld, C.4
Apte-Sengupta, S.5
Frenzke, M.E.6
Forest, A.7
Whidby, J.8
Marcotrigiano, J.9
Rice, C.M.10
-
309
-
-
84875695802
-
Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: A randomized controlled study
-
[CrossRef] [PubMed]
-
Chung, R.T.; Gordon, F.D.; Curry, M.P.; Schiano, T.D.; Emre, S.; Corey, K.; Markmann, J.F.; Hertl, M.; Pomposelli, J.J.; Pomfret, E.A., et al. Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: A randomized controlled study. Am. J. Transpl. 2013, 13, 1047–1054. [CrossRef] [PubMed]
-
(2013)
Am. J. Transpl
, vol.13
, pp. 1047-1054
-
-
Chung, R.T.1
Gordon, F.D.2
Curry, M.P.3
Schiano, T.D.4
Emre, S.5
Corey, K.6
Markmann, J.F.7
Hertl, M.8
Pomposelli, J.J.9
Pomfret, E.A.10
-
310
-
-
22044437431
-
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
-
[CrossRef] [PubMed]
-
Davis, G.L.; Nelson, D.R.; Terrault, N.; Pruett, T.L.; Schiano, T.D.; Fletcher, C.V.; Sapan, C.V.; Riser, L.N.; Li, Y.; Whitley, R.J., et al. A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl. 2005, 11, 941–949. [CrossRef] [PubMed]
-
(2005)
Liver Transpl
, vol.11
, pp. 941-949
-
-
Davis, G.L.1
Nelson, D.R.2
Terrault, N.3
Pruett, T.L.4
Schiano, T.D.5
Fletcher, C.V.6
Sapan, C.V.7
Riser, L.N.8
Li, Y.9
Whitley, R.J.10
-
311
-
-
33748778214
-
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study
-
[CrossRef] [PubMed]
-
Schiano, T.D.; Charlton, M.; Younossi, Z.; Galun, E.; Pruett, T.; Tur-Kaspa, R.; Eren, R.; Dagan, S.; Graham, N.; Williams, P.V., et al. Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study. Liver Transpl. 2006, 12, 1381–1389. [CrossRef] [PubMed]
-
(2006)
Liver Transpl
, vol.12
, pp. 1381-1389
-
-
Schiano, T.D.1
Charlton, M.2
Younossi, Z.3
Galun, E.4
Pruett, T.5
Tur-Kaspa, R.6
Eren, R.7
Dagan, S.8
Graham, N.9
Williams, P.V.10
-
312
-
-
79958291149
-
A genetically humanized mouse model for hepatitis C virus infection
-
[CrossRef] [PubMed]
-
Dorner, M.; Horwitz, J.A.; Robbins, J.B.; Barry, W.T.; Feng, Q.; Mu, K.; Jones, C.T.; Schoggins, J.W.; Catanese, M.T.; Burton, D.R., et al. A genetically humanized mouse model for hepatitis C virus infection. Nature 2011, 474, 208–211. [CrossRef] [PubMed]
-
(2011)
Nature
, vol.474
, pp. 208-211
-
-
Dorner, M.1
Horwitz, J.A.2
Robbins, J.B.3
Barry, W.T.4
Feng, Q.5
Mu, K.6
Jones, C.T.7
Schoggins, J.W.8
Catanese, M.T.9
Burton, D.R.10
-
313
-
-
84884150486
-
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
-
[CrossRef] [PubMed]
-
Dorner, M.; Horwitz, J.A.; Donovan, B.M.; Labitt, R.N.; Budell, W.C.; Friling, T.; Vogt, A.; Catanese, M.T.; Satoh, T.; Kawai, T., et al. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 2013, 501, 237–241. [CrossRef] [PubMed]
-
(2013)
Nature
, vol.501
, pp. 237-241
-
-
Dorner, M.1
Horwitz, J.A.2
Donovan, B.M.3
Labitt, R.N.4
Budell, W.C.5
Friling, T.6
Vogt, A.7
Catanese, M.T.8
Satoh, T.9
Kawai, T.10
-
314
-
-
51349162563
-
Molecular architecture of native HIV-1 gp120 trimers
-
[CrossRef] [PubMed]
-
Liu, J.; Bartesaghi, A.; Borgnia, M.J.; Sapiro, G.; Subramaniam, S. Molecular architecture of native HIV-1 gp120 trimers. Nature 2008, 455, 109–113. [CrossRef] [PubMed]
-
(2008)
Nature
, vol.455
, pp. 109-113
-
-
Liu, J.1
Bartesaghi, A.2
Borgnia, M.J.3
Sapiro, G.4
Subramaniam, S.5
-
315
-
-
33745203490
-
Distribution and three-dimensional structure of AIDS virus envelope spikes
-
[CrossRef] [PubMed]
-
Zhu, P.; Liu, J.; Bess, J., Jr.; Chertova, E.; Lifson, J.D.; Grise, H.; Ofek, G.A.; Taylor, K.A.; Roux, K.H. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 2006, 441, 847–852. [CrossRef] [PubMed]
-
(2006)
Nature
, vol.441
, pp. 847-852
-
-
Zhu, P.1
Liu, J.2
Bess, J.3
Chertova, E.4
Lifson, J.D.5
Grise, H.6
Ofek, G.A.7
Taylor, K.A.8
Roux, K.H.9
|